BINDING, PROTECTION, AND RNA DELIVERY PROPERTIES OF POROUS SILICA NANOPARTICLES IN SPODOPTERA FRUGIPERDA CELLS by Nadeau, Emily
University of Kentucky 
UKnowledge 
Theses and Dissertations--Entomology Entomology 
2017 
BINDING, PROTECTION, AND RNA DELIVERY PROPERTIES OF 
POROUS SILICA NANOPARTICLES IN SPODOPTERA FRUGIPERDA 
CELLS 
Emily Nadeau 
University of Kentucky, eana226@g.uky.edu 
Author ORCID Identifier: 
https://orcid.org/0000-0002-7711-0342 
Digital Object Identifier: https://doi.org/10.13023/ETD.2017.346 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Nadeau, Emily, "BINDING, PROTECTION, AND RNA DELIVERY PROPERTIES OF POROUS SILICA 
NANOPARTICLES IN SPODOPTERA FRUGIPERDA CELLS" (2017). Theses and Dissertations--Entomology. 
39. 
https://uknowledge.uky.edu/entomology_etds/39 
This Master's Thesis is brought to you for free and open access by the Entomology at UKnowledge. It has been 
accepted for inclusion in Theses and Dissertations--Entomology by an authorized administrator of UKnowledge. For 
more information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my thesis or dissertation and abstract are my original work. Proper attribution 
has been given to all outside sources. I understand that I am solely responsible for obtaining 
any needed copyright permissions. I have obtained needed written permission statement(s) 
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine) which will be 
submitted to UKnowledge as Additional File. 
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and 
royalty-free license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless an embargo applies. 
I retain all other ownership rights to the copyright of my work. I also retain the right to use in 
future works (such as articles or books) all or part of my work. I understand that I am free to 
register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of 
the program; we verify that this is the final, approved version of the student’s thesis including all 
changes required by the advisory committee. The undersigned agree to abide by the statements 
above. 
Emily Nadeau, Student 
Dr. Bruce A. Webb, Major Professor 
Dr. Charles Fox, Director of Graduate Studies 
  
 
 
 
 
 
 
BINDING, PROTECTION, AND RNA DELIVERY PROPERTIES OF POROUS 
SILICA NANOPARTICLES IN SPODOPTERA FRUGIPERDA CELLS 
 
 
 
THESIS 
 
A thesis submitted in partial fulfillment of the requirements for the  
degree of Master of Science in the 
College of Agriculture, Food and Environment 
at the University of Kentucky  
 
By 
Emily Allison Wheeler Nadeau 
Lexington, Kentucky 
Director: Dr. Bruce Webb, Professor of Entomology 
Lexington, Kentucky 
2017 
Copyright© Emily A.W. Nadeau 2017 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT OF THESIS 
 
 
 
 
BINDING, PROTECTION, AND RNA DELIVERY PROPERTIES OF POROUS 
SILICA NANOPARTICLES IN SPODOPTERA FRUGIPERDA CELLS 
 
Traditional methods of pest control are threatened by the development of insecticide 
resistance, both to traditional insecticides and Bt toxins.  Discovery of RNA interference (RNAi) 
has created opportunities to develop new insect control mechanisms.  However, RNAi responses 
appear to be robust in coleopteran pests, but other orders, e.g. Lepidoptera and Hemiptera, present 
varied or ineffective RNAi responses.  Current delivery strategies for double-stranded RNA 
(dsRNA) include microinjection, ingestion, and soaking.  These approaches have benefits and 
problems.  This study investigates the potential for porous silica nanoparticles (pSNPs) to 
improve the delivery of dsRNA and induce an RNAi response in Spodoptera frugiperda cells.  
Initially, the binding conditions of RNA onto porous and nonporous silica nanoparticles was 
examined, and the movement of RNA on and within pSNPs was observed.  That information was 
then applied to in vitro studies for examining the capacity of silica nanoparticles to protect 
dsRNA from degradation by nucleases.  This work culminated in an in vivo assay for measuring 
apoptosis when dsRNA is delivered to insect cells by pSNPs.  Results of these studies show that 
silica nanoparticles bind nucleic acids and that dsRNA is mobile, pSNPs protect dsRNA from 
nuclease degradation, and pSNP/dsRNA complexes can induce apoptosis in lepidopteran insect 
cells. 
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Chapter One:  Literature Review 
Current Problems with Pest Control 
Insecticide resistance is a significant challenge for modern agriculture.  
Insecticide resistance has been documented in 602 arthropod species in 21 orders to date 
(Arthropod Pesticide Resistance Database, 2017).  As insects become resistant to 
conventional insecticides, their ranges expand.  An example of these problems occurred 
with the pest Helicoverpa armigera when it was documented for the first time in 
Brazilian cotton and soybean fields in 2013 (Czepak et al. 2013).  One strategy developed 
to combat insecticide resistance was the expression of Bacillus thuringiensis delta 
endotoxins in plants (Baum et al. 2007).  Control of major lepidopteran and coleopteran 
crop pests now rely on this technology but it is limited to a small number of crops (Lim et 
al. 2015).  The need for an alternative pest control strategy that is safe, easy to produce, 
and insect specific is immense.  RNA interference may offer new avenues for pest control 
that include avoiding the cost of developing new insecticide formulations and insecticide 
targets, it does not involve broad spectrum insecticides, and it may help to overcome the 
problem of insects becoming resistant to transgenic plants (Gatehouse and Price 2011).  
RNA Interference  
 
All eukaryotic cells possess the ability to silence sequence-specific gene 
fragments when they encounter double-stranded RNA (dsRNA) (Baum et al. 2007).  
These mechanisms, referred to as RNA interference (RNAi), can silence genes essential 
for processes like feeding or nutrient assimilation, and detoxification of pesticides and 
Bacillus thuringiensis insecticidal proteins.  RNAi targeted at these critical genes can 
result in increased mortality (Baum et al. 2007).  RNAi machinery is activated in cells 
when foreign dsRNAs are identified and spliced into approximately 20-23 base pair (bp) 
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double-stranded nucleotide strands, called small interfering RNAs (siRNAs), by the 
ribonuclease DICER (Bernstein et al. 2001).  One strand of the siRNA is degraded, and 
the other (called the guide RNA) is loaded into the RNA-induced silencing complex 
(RISC) (Hammond et al. 2001).  The guide strand recognizes complementary cellular 
mRNAs (Hammond et al. 2001), and once a cellular mRNA is recognized as 
complementary to the guide strand, RISC cleaves the mRNA, leading to degradation of 
the mRNA so that it is no longer functional (Tomari and Zamore, 2005).  
RNAi Response 
 
There are three types of RNAi response that are relevant for insect control 
applications.  First is cell-autonomous RNAi, where RNA silencing is restricted to the 
cell where dsRNA is injected or naturally expressed (Whangbo and Hunter, 2008).  The 
second is environmental RNAi, where dsRNA is taken up from the lumen by midgut cells 
and induces an RNAi signal that is then replicated in cells beyond the body cavity 
(Whangbo and Hunter, 2008).  Lastly is systemic RNAi, which occurs when RNA and 
RNAi signals are amplified and then spread from a cell where dsRNA is originally 
produced or from a cell that is exposed to dsRNA (Whangbo and Hunter, 2008).  This 
last type of response, which has the most severe organism-wide effects, is the most 
promising for insect control applications. 
RNA Delivery 
 
One challenge to developing RNAi as an insect control method is devising a 
reliable way to induce dsRNA uptake into cells.  The methods for dsRNA uptake in 
invertebrates have been characterized through studies in Caenorhabditis elegans and 
Drosophila melanogaster S2 cells (Lim et al. 2015).  The first mechanism is the Systemic 
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RNAi defective (SID-1 and SID-2) transmembrane proteins system (Lim et al. 2015).  
There are three hypotheses for how this system works.  The first states that upon 
recognizing dsRNA present in the lumen, SID-2 modifies SID-1 into a channel for the 
dsRNA (Whangbo and Hunter, 2008).  Another hypothesis is that SID-2 may also act as a 
receptor for the dsRNA in the lumen (Whangbo and Hunter, 2008).  The third hypothesis 
is the receptor-mediated endocytosis mechanism.  It states that once SID-2 binds to the 
dsRNA, a vacuole forms around the SID-2/dsRNA complex and SID-1, and then the 
vacuole is pulled inside the cell (Whangbo and Hunter, 2008).  Once inside the cell, SID-
1 acts as a channel to release the dsRNA into the cytoplasm (Whangbo and Hunter, 
2008).  The SID-1 channel was first recognized in C. elegans as a requirement for the 
import of RNAi silencing signals (Winston et al. 2002) and was then placed in 
Drosophila S2 cells to show that it had the same function in insect cells (Shih and 
Hunter, 2011).  It is widely recognized in the literature that there is a second mechanism 
for the cellular uptake of dsRNA, but the identity of this second mechanism is debated 
(Hinas et al. 2012;  Shih and Hunter, 2011;  Lim et al. 2015).  Some researchers favor 
evidence for the SID-5 model, an endosomal protein identified in C. elegans (Hinas et al. 
2012), and others support the idea that SID-1 is its own mechanism and that SID-1 and 
SID-2 working together is the second mechanism (Whangbo and Hunter, 2008 and 
Winston et al. 2002, 2007).  
Although DICER is conserved among all insects, the response to RNAi is highly 
variable between insect orders (Lim et al. 2015).  Certain orders, specifically 
coleopterans, show much more substantial RNAi responses than others such as 
Lepidoptera (Bellés, 2010).  These differences in RNAi response have been explained by 
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the presence or absence of dsRNA cellular import and export mechanisms, the absence of 
RNAi signal amplification, and nuclease activity in cells that degrades dsRNA (Bellés, 
2010;  Gatehouse and Price, 2011;  Gu and Knipple, 2013;  Terenius et al. 2011).  This 
disparity in RNAi effectiveness is a major hurdle to the use of the technology for control 
of lepidopteran pests.  
One major challenge in the development of more effective RNAi technology is 
the reliable delivery of dsRNA into cells.  The strategies to deliver dsRNA to cells and 
insects include microinjection, ingestion, and soaking (Yu et al. 2013).  These strategies 
are effective in some insects but have distinct limitations.  The major advantage of 
microinjection is that dsRNA is immediately delivered to the specific tissue or the 
hemolymph, and other barriers such as the integument are bypassed.  Also, the exact 
amount of dsRNA delivered is known, which is difficult to determine with the other 
methods.  However, there are some distinct disadvantages to microinjection.  
Specifically, microinjection is technically difficult, expensive, and time consuming.  
Ingestion of dsRNA can be done in two ways: either supplying a liquid diet saturated 
with dsRNA or feeding insects bacteria that express dsRNA (Yu et al. 2013).  Ingestion 
studies have been conducted in numerous insects, including species from the orders 
Lepidoptera, Coleoptera, Ixodida, Isoptera, Hemiptera, and Diptera (Yu et al. 2013).  The 
advantages to oral ingestion include ease of production and performance (Tian et al. 
2009), ease of high-throughput screening applications (Kamath et al. 2000), and it is less 
invasive and more practical than injection, especially for smaller insects (Araujo et al. 
2006;  Tian et al. 2009;  Walshe et al. 2009).  Disadvantages include evidence that it is 
not suitable for all insects, as discussed by Araujo et al. 2006 and Rajagopal et al. 2002, 
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for various reasons.  Soaking is most often done for cell lines (Yu et al. 2013).  This 
method is advantageous because it is convenient and easy to perform, facilitating high-
throughput screening (Yu et al. 2013 and Wang et al. 2011).  It is unclear, however, how 
soaking methods translate to the organismal scale due to the added challenge of 
penetrating the cuticle during application (Yu et al. 2013).  The limitations of current 
dsRNA delivery methods motivate the search for new and more effective strategies. 
Alternative Delivery Strategies 
 
Aside from these three main methods, there are other approaches that are less 
common.  These include electroporation (Karim et al. 2010), liposome encapsulation 
(Whyard et al. 2009), incorporation of dsRNA into plant tissues (Zhang et al. 2013), and 
nanoparticle delivery systems (He et al. 2013 and Zhang et al. 2010).  Nanoparticle is a 
general sized based descriptor of particles having diameters between 10 nm and 1000 nm, 
but there is immense variety in nanoparticle composition.  To date, there have been four 
studies that used a nanoparticle to overcome challenges for the delivery of dsRNA to 
whole insects (Das et al. 2015).  
 Using Nanoparticles in Insects for RNAi 
 
Zhang et al. (2010) utilized chitosan nanoparticles bound to two chitin synthase 
genes to increase insecticide sensitivity in Anopheles gambiae.  Their goal was to analyze 
the ability of nanoparticles to efficiently deliver siRNA to aquatic larvae, which is a 
system currently lacking an appropriate dsRNA delivery system.  Chitosan nanoparticles 
were commonly used for therapeutic plasmid delivery (Howard et al. 2006 and Zhang et 
al. 2010).  These particles are used as self-assembling nanoparticles that do not require 
finely-tuned engineering.  The study of Zhang et al. (2010) also lacked any in vitro 
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investigation into how the dsRNAs interacted with the chitosan-based nanoparticles or 
whether the nanoparticles protected the dsRNA from environmental factors such as gut 
pH and nuclease activity.  Although this system increased insecticide sensitivity, the lack 
of in vitro information was one of the gaps that we sought to address in our study and 
design of a nanoparticle delivery system.  
He et al. (2013) also used nanoparticles as a tool for enhancing RNAi in insects.  
These researchers recognized that nanoparticle physicochemical properties can be 
precisely controlled and fine-tuned to produce low cytotoxicity responses while also 
ensuring high transfection efficiency.  They used a diet that contained cationic core-shell 
fluorescent nanoparticles (FNPs) bound to the dsRNA to cause knockdown of the 
chitinase-like gene CHT10 in the Asian corn borer, Ostrinia furnacalis.  They performed 
no initial in vitro studies to explore how FNPs interacted with and protected dsRNA 
before studying in vivo applications, although they found that chitinase-like dsRNA/FNP 
complexes fed to larvae increased larval mortality.  One extremely important observation 
they made is that they determined that FNPs can pass through the peritrophic membrane, 
as fluorescent particles were observed inside gut cells.  They also observed accelerated 
endocytosis in gut cells that had taken up the dsDNA/FNP complexes, which did not 
occur with DNA, and found that FNPs are likely excreted by exocytosis, thereby 
avoiding cytotoxicity.  But like Zhang et al. (2010), no in vitro studies were done before 
in vivo applications.  
The third paper compared the use of chitosan nanoparticles, carbon quantum dots, 
and the first use of silica nanoparticles, for dsRNA delivery to insects (Das et al. 2015).  
This study quantified RNA binding ability of the three types of particles and discovered 
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that amine functionalization is a requirement for RNA binding to silica nanoparticles, a 
result which was later validated by Möller et al. (2016).  This observation was the major 
in vitro study before the RNA/particle complexes were fed to Aedes aegypti larvae.  After 
feeding amine functionalized nanoparticles loaded with the dsRNA of SNF7 and SRC to 
Ae. aegypti larvae, they found no mRNA knockdown or increased larval mortality.  The 
study concluded that the other two delivery vehicles, carbon quantum dots and self-
assembling chitosan/dsRNA complexes, were superior dsRNA delivery vehicles in 
insects.  However, the silica nanoparticles Das et al. (2015) used were purchased and they 
did not control their engineering.  The purchasing of generic nanoparticles may be 
problematic as it does not control or characterize the physicochemical properties of 
nanoparticles, or allow modification of these properties accordingly.  To make silica 
nanoparticles efficient nucleic acid carriers some degree of malleability may be required.  
The final paper that investigated a nanoparticle delivery system was Thairu et al. 
(2017).  To overcome traditional siRNA delivery methods in nonmodel insects for the 
study of gene function, they used aerosolized siRNA/nanoparticle complexes to deliver 
siRNA to three species of aphids.  They then compared the fate of dsRNA alone after 
microinjection and dsRNA aerosolized to nanoparticles delivered through the tracheoles.  
The conclusion of this paper was that the aerosolized siRNA/nanoparticle complexes can 
protect siRNA from degradation but only produced an RNAi response in one of the three 
species tested.  This paper reinforces our belief that nanoparticles can be an effective 
dsRNA delivery system, capable of producing an RNAi response, under the appropriate 
conditions, which specifically includes the appropriate gene target, the siRNA amount, 
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and route of delivery.  However, controlling these conditions to optimize RNA delivery 
and develop a viable RNAi insect control technique may be required in lepidopterans.   
In contrast to entomological studies, an extensive amount of work has been done 
in other systems over the past decade to characterize the interactions between 
nanoparticles and biological molecules because nanoparticles have been recognized as an 
important delivery mechanism (Möller et al. 2016).  Initially, mesoporous silica 
nanoparticles were investigated as a chemotherapy drug delivery system (Slowing et al. 
2008).  The need for target specific chemotherapies was a driving force in the 
development of mesoporous silica nanoparticles (MSN) to meet the following criteria:  
biocompatibility with target cells, large loading capacity of molecules, complete 
encapsulation of molecules that ensured no early release, and a controlled release once 
the MSNs entered target cells (Slowing et al. 2008).  Other delivery vehicles have been 
investigated, such as polymeric nanoparticles, dendrimers, and liposomes, but these 
vehicles had a “leaking” problem, wherein the molecule being delivered left the vehicle 
prematurely and was degraded.  Silica was investigated as a molecular delivery system 
because of its stability, the ease of modifying its physicochemical properties, it’s 
biocompatible with cells, and the large surface area provided by pores for nucleic acid 
binding and protection of nucleic acids from the environment.  As the benefits of MSNs 
were realized, it became necessary to optimize surface chemistry, produce uniform 
internal pores, and understand how different molecules interact with the MSNs. 
Researchers found that the silica surface can be amine functionalized, which adds 
a positive charge to the particle.  Internal particle surfaces, within the pores, can be 
functionalized with basic, acidic, or hydrophobic residues to support binding with the 
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payload molecules (Möller et al. 2016).  For siRNA delivery, the porous MSNs (pSNP) 
must be positively charged to bind to the negatively charged siRNA molecules and to cell 
membranes to enable their entrance into cells and stabilize the siRNA in environments 
where siRNA may be degraded (Möller et al. 2016).  The pSNPs can be positively 
charged by condensing positively charged aminosilanes onto the surface of the particle 
(Xiong and Qiao 2016 and Lin et al. 2013).  Other positively charged molecules that can 
be used include metal ions, cationic polymers, and peptides.  Biocompatibility with the 
cells is achieved by coating the particle surface in polyethyleneimine polymers (PEI) or 
lipid bilayers (Buchman et al. 2013 and Ashley et al. 2012).  PEI and lipid bilayers 
eliminate electrostatic interactions and thus reduce cytotoxicity (Xia et al. 2009).  
Preliminary experiments in our lab indicated that lipid bilayers limit uptake of pSNPs 
into insect cells and so this study focuses on an aminosilane as the optimal modification 
to investigate.  
I investigated the use of porous silica nanoparticles, which have numerous 
benefits including reduced cytotoxicity (Di Pasqua et al. 2008), high surface and internal 
malleability, and possess a large dsRNA loading capacity (Möller et al. 2016).  Although 
nanoparticles have a low cytotoxicity, some cytotoxicity to human neuroblastoma cells 
has been recorded and may be caused by the adsorptive surface area of the particle or the 
properties of the functional group attached to the particle surface (Di Pasqua et al. 2008).  
In some cases, PEI can cause apoptosis, but researchers have found that this may depend 
on cell type and the molecular weight of the PEI molecules (Florea et al. 2002 and Xia et 
al. 2009).  The pSNPs utilized in this study did not contain PEI, and thus avoided the 
possibility of the PEI surface modification increasing apoptosis.  The surface area of the 
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nanoparticles utilized in this study are amine functionalized pSNPs ranged from 14.4 to 
585 m2/g, which ensured that there were sufficient binding sites for dsRNA molecules.  
M. Arif Khan produced three pore sizes of pSNPs:  1.58 ± 0.14 nm, 3.24 ± 0.38 nm, and 
7.55 ± 1.92, with pore volumes of 0.57, 0.66, and 1.50 cm3/g, respectively.  This 
capability provides this study with a range of pSNPs for study with pores equal to and 
larger than the diameter of dsRNAs.  Fluorescently labeled dsRNAs of three sizes:  84 
base pairs (bp), 184 bp, and 282 bp were made that were also biologically relevant, from 
slightly larger than siRNAs to sizes that are routinely used for gene silencing experiments 
in insects (several hundred base pairs).  
These 12 dsRNA/pSNP combinations were studied in detail to investigate how 
nucleic acids interact with nanoparticles, how these interactions influence the protection 
and delivery qualities of nanoparticles, and how this information can be applied in vivo in 
insect cells.  This information is critical to design and synthesis of a functional 
nanoparticle delivery system that is required to make RNAi an effective strategy for 
control of insects that do not respond robustly to dsRNAs.  Understanding the 
interactions of nanoparticles, nucleic acids, and the cells they are delivered to is critical 
for maximizing chances of success and troubleshooting initial failures that are to be 
anticipated in the design of a functioning dsRNA delivery system for control of a wide 
spectrum of insect pests. 
Impact and Big Picture 
 Prior work has shown that nanoparticles loaded with dsRNA can be used to 
weaken insects before insecticide treatment (Zhang et al. 2010 and He et al. 2013), 
suggesting that a combination of RNAi and insecticide treatment could represent an 
integrative management strategy that delays the development of insecticide resistance in 
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target pest species.  Beyond weakening insects to insecticides, nanoparticles may be 
useful in RNAi to enhance protection of dsRNA from degradation and uptake by insect 
cells.  There are many types of nanoparticles that can be used, including chitosan, metals 
like silver and gold, and other nontoxic polymers, but we chose to use silica nanoparticles 
because they are nontoxic and easy to manipulate (Zhang et al. 2010).  In addition to the 
low impact to non-target species, silica nanoparticle technology could be applied to 
RNAi-insensitive insects to induce an RNAi response.  Enhancing siRNA delivery may 
enhance RNAi efficacy, but there may still be other factors restricting the use of RNAi as 
a control strategy in RNAi-insensitive insects.  If that is the case, then nanoparticles could 
still be used to control RNAi-sensitive insects.  This technology is easy to manipulate and 
could be used as a new form of pest control.  To study this new technology, we 
collaborated with Dr. Barbara Knutson and Dr. Steve Rankin from the Department of 
Engineering at the University of Kentucky and developed the following three objectives 
that comprise the body of this thesis. 
 
Objective 1:  Characterize the binding and dissociation properties of RNA to porous 
and nonporous silica nanoparticles.  
 
Objective 2:  Characterize the ability of porous and nonporous silica nanoparticles to 
protect dsRNA against cellular RNase activity.  
 
Objective 3:  Analyze efficacy of RNA and silica nanoparticle complexes to induce an 
RNAi response in Spodoptera frugiperda cells.  
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Chapter Two:  dsRNA Interactions with Porous Silica Microparticles:  RNA 
Binding and Mobility 
INTRODUCTION 
Nanoparticles, microscopic particles measuring between 10 nanometers (nm) and 
1000 nm, have been used to deliver nucleic acids and proteins to eukaryotic cells and 
organisms, both plant and animal (He et al. 2013;  Zhang et al. 2010;  Xia et al. 2009;  
Torney et al. 2007).  In insects, nanoparticles have been investigated for their potential to 
deliver nucleic acids to several species with some success (He at al. 2013;  Zhang et al. 
2010;  Thairu et al. 2017;  Das et al. 2015).  However, ‘nanoparticle’ is a general, size-
based, descriptive term for an array of particles having divergent characteristics, diverse 
compositions and under-studied chemistry.  Nanoscale interactions between nucleic acids 
and nanoparticles are likely to exhibit novel phenomena and characteristics, providing 
strong rationale for the systematic investigation of the physicochemical interactions 
between nanoparticles and nucleic acids of specific composition and sequence.  Further, 
some classes of nanoparticles, having physicochemical properties that can be controlled 
and modified, may be engineered for properties that support their use as carriers of 
biological macromolecules.  Here, we investigate the interactions between double-
stranded RNA (dsRNA) and porous silica nanoparticles (pSNPs).  pSNPs are versatile, 
tractable nanoparticles that are readily functionalized and bind to a variety of molecules, 
such as nucleic acids, pharmaceuticals, and lipids.  pSNPs are also highly biocompatible 
with cells, in that they can easily pass through cell membranes and safely deliver 
molecules associated with the nanoparticle to the cell’s interior (Möller et al. 2016).  
pSNPs are highly suited to macromolecule delivery because pore size can be controlled, 
surface characteristics predictably modified and they have a large nucleic acid loading 
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capacity (Möller et al. 2016).  Here we investigate the relationship between dsRNA and 
pSNPs under selected, biologically relevant conditions.  
The potential for pSNPs to deliver protein to cells and protect cargo proteins from 
proteases was studied because these characteristics are relevant to the use of pSNPs for 
delivery of proteinaceous drugs, as well as use for chemical syntheses, as biosensors, and 
in bioseparations (Schlipf et al. 2013).  pSNPs were shown to readily take up proteins and 
protect them from protease digestion in a pore-size dependent manner.  Similarly, pSNPs 
were assessed for their ability to take up RNA by Möller et al. (2016) and nucleic acids 
were shown to bind to amine functionalized pSNPs.  While the associations between 
pSNPs and proteins were clearly impacted by protein size, the characteristics of the 
nucleic acid partner in pSNP-dsRNA interactions are not well defined in the published 
literature.  More generally, the potential for other types of nanoparticles to deliver 
dsRNA to insects has been assessed in a limited number of non-coleopteran pests in 
hopes of expanding the efficacy of RNAi (Zhang et al. 2010;  He at el. 2013;  Das et al. 
2015;  Thairu et al. 2017).  But again, the impacts of dsRNA length or sequence 
composition have not been investigated.  
Delivery of dsRNA to insect cells is of interest because of its potential to induce 
an RNA interference (RNAi) response.  RNAi is an immune system in all eukaryotic 
cells that recognizes and degrades exogenous double-stranded RNA (dsRNA).  The 
RNAi system is also used to regulate gene expression in many Eukaryotes and for 
suppressing gene expression for research and commercial purposes (Baum et al. 2007).  
When cells encounter dsRNA of a viral or artificial origin, gene silencing occurs through 
activation of ribonucleases that target the sequence of the dsRNA encountered by the 
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cell’s RNAi machinery (Bernstein et al. 2001).  Initially, foreign dsRNAs are recognized 
and cleaved into short, 21-23 base pair (bp), double-stranded molecules (small interfering 
RNAs or siRNAs) by the ribonuclease DICER (Bernstein et al. 2001).  These siRNAs are 
loaded into the RNA-induced silencing complex (RISC) where one strand is degraded 
and the other, called the guide strand, is used to identify complimentary, native mRNAs 
(Hammond et al. 2001).  Once a cellular mRNA is recognized by the siRNA/RISC 
complex, RISC cleaves the mRNA and the mRNA is degraded.  
Potentially, RNAi may be useful for the control of insect pests, but researchers 
have found that RNAi efficacy is highly variably for suppression of targeted genes 
among several insect orders (Lim et al. 2016).  For instance, dsRNA can be designed to 
target essential insect mRNAs such as those required for feeding and detoxication of 
pesticidal proteins, thus RNAi can decrease fitness and increase mortality (Baum et al. 
2007).  This approach, while highly efficient in some species, such as coleopterans, 
others, notably lepidopterans, show little or no RNAi response (Bellés, 2010;  Gatehouse 
and Price, 2011;  Baum and Roberts, 2014;  Huvenne and Smagghe, 2010).  There are 
three main hypotheses for why RNAi produces less effective responses in lepidopterans.  
The first is that coleopterans, which produce robust RNAi responses, contain dsRNA 
cellular import and export mechanisms while lepidopterans do not.  A second hypothesis 
is that RNAi signal amplification, a process whereby cells exposed to exogenous dsRNA 
can amplify RNAi signals with an RNA-dependent RNA polymerase, which is necessary 
for systemic RNAi responses, is reduced or absent in lepidopterans (Gatehouse and Price, 
2011).  The third hypothesis is that high levels of nuclease activity are found in 
lepidopteran cells and hemolymph (and presumably in other insect orders with reduced 
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RNAi responses) and these RNases degrade dsRNA before it encounters target cells 
(Bellés, 2010;  Gatehouse and Price, 2011;  Gu and Knipple, 2013;  Terenius et al. 2011).  
If the barriers to the effective use of RNAi in insects could be overcome, RNAi could 
become an advantageous technology for the control of lepidopterans and other insect 
pests.  
One potential strategy to efficiently and effectively deliver dsRNA to insect cells 
is to engineer the nanoparticle so that it becomes an improved dsRNA delivery vehicle.  
Conventionally, dsRNA has been delivered to insect cells and insects by microinjection 
of RNA, ingestion of RNA, or soaking the insect or insect cells in an RNA-containing 
solution.  Other, less conventional methods, such as electroporation, liposome 
encapsulation, and in planta RNA expression have also been explored (Karim et al. 2010;  
Whyard et al. 2009;  Zhang et al. 2013).  However, most nanoparticles are relatively 
fixed in their physicochemical properties and little effort has been directed to optimize 
nanoparticle properties to support efficient dsRNA delivery to insect cells or insects. 
There are several criteria to be considered for optimization of nanoparticles for 
dsRNA delivery, notably pSNP charge, nanoparticle and pore size, and the presence or 
absence of membranes on the pSNP surface.  To enhance association between 
nanoparticles and dsRNA, nanoparticles are amine functionalized, thereby coating the 
nanoparticle with a positive charge.  The positive charge may be conveyed by molecules 
such as aminosilane, metal ions, cationic polymers and peptides (Xiong et al. 2016 and 
Lin et al. 2013).  Nanoparticles can also be coated with polyethyleneimine (PEI) 
polymers or supported bilayers, which eliminate electrostatic interactions between 
negatively charged dsRNA molecules and negatively charged cell membranes (Buchman 
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et al. 2013 and Ashley et al. 2012).  When specific cells are being targeted, nanoparticles 
may be coated with particular ligands or peptides to enhance binding (Tarn et al. 2013).  
Because there is some data indicating that silica nanoparticles are not cytotoxic in 
mammalian cells (Di Pasqua et al. 2008), the nanoparticle and pore size can be controlled 
and they are readily amidated by aminosilane treatment, these particles were selected for 
study.  
Design and synthesis of nanoparticles for dsRNA delivery should be based upon 
an understanding of interactions between dsRNA length, dsRNA concentration, and 
pSMP pore size.  However, nanoparticle properties are difficult to visualize and study by 
light microscopy because of their size.  To more effectively visualize and understand 
dsRNA-pSNP interactions, we utilized microparticles, which have diameters between 5 
µm to 15 µm and are thus large enough to be seen with confocal microscopy, and so are 
amenable to analyses using confocal microscopy such as fluorescence recovery after 
photobleaching (FRAP) analysis.  Thus, microparticles are a model for nanoparticle-RNA 
interactions that allow us to visualize and describe the system.  Because the 
microparticles and nanoparticles have the same surface functionality, are made of the 
same materials, and have equivalent pore sizes, the information gathered in investigations 
of microparticle-RNA interactions is directly relevant to the design and optimization of 
nanoparticle-RNA interactions.  
 
MATERIALS AND METHODS 
Cell Culture 
To gather Sf9 DNA, Sf9 cells were cultured in Sf-900 II serum-free media 
(GibcoTM Cell Culture) per established protocols (O’Reilly et al. 1994).  Cells were 
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maintained and passaged as adherent monolayer cultures in 25 cm2 tissue-culture flasks 
(Corning, Corning, NY) at 32°C.  Cell density and viability was determined using a 
Trypan Blue dye exclusion assay and a hemocytometer.  
Synthesis of dsRNA 
 
Sf9 DNA was extracted from cultured cells by phenol-chloroform extraction 
(Thermo Fisher Scientific, Waltham, MA) per the manufacturer’s protocol, and this DNA 
was used in PCR reactions to amplify the defined sections of the IAP gene.  To 
synthesize dsRNAs of several lengths, segments of the Spodoptera frugiperda Inhibitor 
of Apoptosis (IAP) gene (GenBank: AF 186378.1) were amplified using the PCR and 
IAP sequence-specific primers containing T7 promoters.  dsRNAs were then synthesized 
from PCR templates by in vitro transcription.  Table 2.2 contains the specific primer 
sequences used to amplify two segments of the IAP gene:  IAP84 (84 bp), and BIR2 (282 
bp) amplicons.  These two RNA sizes were selected to allow transcription of dsRNAs of 
a size like silencing RNAs after processing by DICER and to larger RNAs typically used 
to activate RNAi responses in insects.  The IAP gene was chosen because when IAP 
dsRNA is used in RNAi, a characteristic phenotypic apoptotic response is induced 
(Bernsetin et al. 2001 and Tuschl et al. 1999).  BIR2 is a functional domain within the 
coding sequence of the IAP gene, and IAP84 is a segment of the BIR2 domain (Huang et 
al. 2000).  Each 25 µL PCR reaction was prepared at room temperature and contained the 
following:  2.5 µL 10X PCR buffer, 1.5 µL MgCl2 (50 mM), 2.0 µL dNTP mix (10 mM), 
0.5 µL forward primer (100 mM), 0.5 µL reverse primer (100 mM), 0.25 µL Taq 
Polymerase (Invitrogen, Waltham, MA), 1.0 µL Sf9 DNA, and 16.75 µL nuclease-free 
H2O.  PCR reactions were run on a PTC-200 DNA Engine (Bio-Rad, Hercules, CA) with 
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the following cycling parameters:  initial denaturation at 95°C for 30 sec, followed by 30 
cycles of denaturation at 95°C for 30 sec, annealing at 58°C for 30 sec, and extension at 
68°C for 30 sec, and a final extension incubation at 68°C for 5 min.  
Five µL of each PCR product was analyzed on a 1.75% agarose gel to confirm 
that amplicons were of the designed product length.  For dsRNA synthesis, PCR products 
for IAP84 and BIR2 were purified using the Fermentas GeneJET PCR Purification Kit 
(Fermentas, Waltham, MA) per the manufacturer’s protocol.  
Fluorescently labelled BIR2 and IAP84 dsRNAs were synthesized using the 
HiScribe T7 High Yield RNA Synthesis Kit (New England Biolabs, Ipswich, MA).  The 
reaction mixture was prepared at room temperature and contained the following:  2.0 µL 
10X T7 reaction buffer, 2.0 µL ATP (100 mM), 2.0 µL GTP (100 mM), 2.0 µL CTP (100 
mM), 1.5 µL UTP (100 mM), 0.5 µL fluorescein-12-UTP (250 nmol, Roche, Basel, 
Switzerland), approximately 10 ng purified PCR product template, 2.0 µL T7 RNA 
polymerase mix, and nuclease-free H2O.  The final volume was 20 µL.  Samples were 
vortexed and incubated at 37°C overnight.  
 After the overnight incubation, dsRNA samples were left at room temperature for 
5 min to allow for annealing of single stranded RNA molecules.  Newly synthesized 
dsRNA samples were quantified on a NanoDrop 2000 Spectrophotometer (Thermo Fisher 
Scientific, Waltham, MA) and then diluted 1:4 in nuclease-free H2O.  7.2 µg of each 
diluted sample was combined with nuclease-free H2O for a total volume of 31 µL.  Size 
and purity of dsRNA samples were then verified on 2% agarose gels.  
 Mesoporous Silica Microparticle Solutions 
 Santa Barbara amorphous silica batch nonporous microparticles (SMPs) and silica 
mesoporous microparticles (pSMPs) were synthesized and provided by Shanshan Zhou in 
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the lab of Dr. Barbara Knutson and Dr. Steve Rankin using methods modified from those 
described by Schlipf et al. (2013).  Detailed description of the syntheses of SMP and 
pSMP synthesis are provided elsewhere (Appendix A).  Four types of microparticles 
were synthesized:  amine functionalized nonporous silica particles, amine functionalized 
pSMPs with an average pore size of 3.0 ± 0.9 nm (“3.6 nm pSMPs”), amine 
functionalized pSMPs with an average pore size of 7.2 ± 1.2 nm (“7.4 nm pSMPs”), and 
amine functionalized pSMPs with an average pore size of 11.3 ± 3.0 nm (“11.8 nm 
pSMPs”).  The particle name is based on pore sizes of these particles prior to amine 
functionalization.  The average pore size after amine functionalization is somewhat 
smaller than the particle names.  Microparticle stock solutions were made up in 
concentrations of 10 mg/mL in nuclease-free H2O.  Before use, pSMP stock solutions 
were sonicated using a Tekmar Sonic Disruptor for 15 seconds (Teledyne Tekmar, 
Mason, OH) to resuspend particles in the solution.  After the initial sonication, all pSMP 
solutions were vortexed with a Vortex Genie 2 (Thermo Fisher Scientific, Waltham, MA) 
for 15 seconds immediately before use.  
 dsRNA Loading onto Microparticles 
 
 To support dsRNA binding to pSMPs, the pSMPs were positively charged by 
amine functionalization (Appendix A).  dsRNAs will then bind to pSMPs in aqueous 
solutions ranging from pH 5-9.  dsRNA was bound to pSMPs by adding 0.25 mg dsRNA 
to 0.25 mg pSMP.  To track RNA binding to microparticles in these studies, 1 µL of 
fluorescently labeled IAP84 (concentration=12.67495 µg/µL) was added to RNA 
solutions before allowing the RNA to associate with microparticles.  This allowed 
visualization of microparticle-RNA binding and mobility.  Five µL of each of the four 
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types of microparticles (concentration=10 mg/mL) were combined with 14 µL of RNase-
free H2O.  Samples were vortexed and shaken on a 55S 12 x 16 Single Platform 
Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at room temperature for 
one hour to allow for dsRNA attachment.  To remove any unbound dsRNA in solution, 
samples were centrifuged for 20 seconds to pellet the pSMP/dsRNA complexes (Thermo 
Fisher Scientific, Waltham, MA) and aqueous supernatants were removed from each 
sample and discarded.  To wash dsRNA/pSMP complexes, 47 µL of RNase-free H2O was 
added to each sample, which was then vortexed and centrifuged, and then the aqueous 
fraction was removed as described above.  The washing step was repeated 3 times.  
Finally, samples were spun down in a microcentrifuge at 6,300 x g (Thermo Fisher 
Scientific, Waltham, MA) for 30 seconds to pellet the pSMP/dsRNA complexes, which 
were then assessed by confocal microscopy. 
 Photobleaching to Measure Fluorescence Recovery 
 
Fluorescein-12-UTP labeled dsRNA was excited at 488 nm with an argon laser at 
8% laser power for imaging.  Emission was collected between 500 nm and 600 nm.  
Photobleaching experiments were performed at 20°C over a x63/1.3 oil immersion 
objective.  One image was captured prior to bleaching.  Then, a 500-nm diameter disk 
was bleached once at 75% laser power.  Five images were captured at the fastest capture 
rate of 1.3 seconds, five images were captured at 3 second intervals, and finally 20 
images were captured at 10 second intervals.  All imaging and fluorescence recovery 
after photobleaching (FRAP) experiments were conducted on a Leica TCS SP5 Confocal 
Microscope (Leica Microsystems, Wetzlar, Germany).  
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RESULTS AND DISCUSSION 
 To investigate the potential for pSNPs to associate with and deliver RNA to cells, 
this study used micron-sized particles having pores of similar dimensions to pSNPs.  A 
similar approach was used by Schlipf et al. (2013) to investigate binding of proteins to 
porous silica micro- and nanoparticles and protection of bound proteins from proteolysis.  
As the physical characteristics of dsRNA, a predominantly linear molecule, and globular 
proteins differ significantly, RNA and silica nanoparticles may interact in very different 
ways.  Further, the features of RNA length and sequence composition may also impact 
dsRNA-pSNP interactions.  
 To investigate the relationship between dsRNA and porous silica microparticles 
(pSMPs), dsRNAs of two lengths were synthesized (84 base pairs [bp] and 282 bp).  The 
size of these dsRNAs was selected to mimic and allow the study of short dsRNAs that are 
like silencing RNAs produced by DICER catalysis and larger RNA templates typically 
used to activate the DICER system.  These RNA targets were designed from the S. 
frugiperda IAP gene as suppression of genes that inhibit apoptosis in cells induces 
apoptosis, thereby producing a visible phenotype.  Concurrently, four types of amine 
functionalized pSMPs (nonporous, 3.6 nm porous, 7.4 nm porous, and 11.8 nm porous) 
were synthesized to study the effects that pores of differing sizes have on RNA-silica 
particle interactions.  These pore sizes were selected with consideration for the 2-nm size 
of double-stranded nucleic acids and expected to provide restricted access at the 3.6 nm 
pore size and relatively free access at the larger pore sizes.  Finally, we labeled a fraction 
of dsRNAs with a fluorescein-12-UTP nucleotide to allow visualization of the RNA 
partner in these association studies and optimized relative concentrations of dsRNA and 
pSMPs.  The results of these preliminary experiments were to standardize conditions for 
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the study of pSMP-dsRNA interactions.  Briefly, the RNA and silica particles were used 
at a concentration of 0.25 mg dsRNA/mg pSMPs, in neutral, aqueous solution.  The 
fluorescein-labeled dsRNA used for visualization by confocal microscopy was otherwise 
identical to the unlabeled dsRNA and represented 6.25% of the dsRNA in experiments.   
 Loading Silica Microparticles with Labeled dsRNA 
 Figure 2.1 shows dsRNA loading of dsRNAs of 282 and 84 bp onto the selected 
types of particles.  The images are optical sections of the microparticles with fluorescence 
showing the locations of bound RNA.  Only surface binding was present for both 
dsRNAs when bound to nonporous microparticles.  Nonporous particles lack interior 
pores and as expected, only surface binding is evident in this experiment.  In contrast, the 
shorter dsRNA, IAP84 (84 bp) was evident throughout pSMPs of all classes (3.6 nm 
pSMPs, 7.4 nm pSMPs, and 11.8 nm pSMPs), indicating that the 84 bp dsRNA can 
readily enter all three pSMP pore sizes.  This result suggests that dsRNAs equal to or 
smaller than 84 base pairs can efficiently enter the three pore sizes that were tested.  
Interestingly, the larger 282 bp dsRNA fragment exhibited pore-size dependent 
differences in pSMP binding.  With 3.6 nm pSMPs, only surface binding was observed, 
which was similar to binding of the RNA to nonporous particles.  As pore size increased, 
the BIR2 dsRNA was detected throughout the interior of the particle. 
These data indicate that larger RNA (282 bp or larger) are unable to enter pores of 
3.6 nm or smaller.  This constraint on RNA loading suggests that dsRNAs do not readily 
thread into the particle’s pores.  The larger pore sizes (7.4 nm and greater) do not show 
evidence of this constraint, indicating that it is not simply an issue of orienting the 
dsRNA relative to the pore that influences loading.  To further investigate the influence 
23 
 
of dsRNA length and pore size on dsRNA loading onto pSMPs, we performed 
fluorescence recovery after photobleaching (FRAP) analyses which allows the mobility 
of fluorescently labeled dsRNA molecules on the pSMP to be measured (Fig. 2.2).  
 IAP84 Diffusivity in Different Pore Sizes of pSMPs 
 To assess the mobility of experimental dsRNAs that can freely enter pSMPs of all 
tested pore sizes, a fluorescently labeled 84 bp dsRNA, known as IAP84, was associated 
with nonporous SMPs and pSMPs that have pores of 3.6, 7.4, or 11.8 nm.  FRAP utilizes 
transient exposure to a laser to bleach a fluorescent area, inactivating the signal from the 
labeled dsRNAs on the surface of the microparticle (Fig. 2.2).  The recovery of 
fluorescence, known as the diffusivity, is a direct observation of unbleached, 
fluorescently-tagged dsRNA moving into the area that was bleached by exposure to the 
laser.  This enables the mobility of the dsRNA molecules to be measured.  To assess 
RNA mobility at different regions within the microparticle, optical sections can be taken 
from the surface of the particle after bleaching, known as the “cap” measurement.  To 
measure interior mobility, optical sections within the particle, known as the “core” 
measurement, can be used.  Thus, dsRNA mobility, or diffusivity, can be measured on 
the surface and in the interior.  RNA mobility on nanoparticles may be related to the 
ability of a particular class of nanoparticles to take up and release RNA.  As induction of 
the RNAi response requires the cell’s DICER system to detect and respond to the 
presence of RNA in a cell, RNA which is not released from a nanoparticle may be less 
effective in inducing an RNAi response.  
When FRAP analyses were performed with the experimental dsRNAs, IAP84 and 
BIR2, to measure RNA mobility on the surface of nonporous silica microparticles, 
diffusivity was measured at zero (Table 2.1).  These data indicate that the RNA bound so 
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strongly to the particle surface that it did not move, suggesting that nonporous silica 
nanoparticles may not be an optimal vehicle for delivery of dsRNA to cells.  
Interestingly, when diffusivity of IAP84 and BIR2 dsRNAs were measured by FRAP 
analyses these dsRNAs appeared to move readily with mobility increasing in a non-linear 
manner as pSMP pore size increased (Table 2.1).  This suggests that smaller dsRNAs can 
move freely within a wide range of pore diameters and this conclusion is important in 
designing dsRNA/pSMP complexes for the delivery of dsRNAs to insect cells.  
Perhaps surprisingly when considering the lack of mobility on nonporous 
particles, the IAP84 dsRNA was quite mobile at both the center of the 3.6 nm pSMP (the 
“core” measurement), and at the surface of the particle (the “cap” measurement).  
Diffusivity was measured at 2.45E-04 ± 5.49E-05 µm2/second for IAP84 dsRNA at the 
surface of the 3.6 nm pSMP, while the “cap” measurement was 2.91E-04 ± 1.11E-04 
µm2/second.  Interestingly, the increase in dsRNA mobility increased disproportionately 
to the increase in pore size;  a 2.84-fold increase in mobility was observed with a 
doubling in pore size from 3.6 to 7.4 nm, whereas the increase from 7.4 to 11.8 nm 
resulted in an increase that was more proportional to the increase in pore size.  Core 
mobility of IAP84 dsRNA associated with the 7.4 nm pSMP was 8.47E-04 ± 1.85E-04 
µm2/second.  Cap mobility of IAP84 dsRNA associated with the 7.4 nm pSMP was 
8.26E-04 ± 2.66E-04 µm2/second.  The core mobility of IAP84 dsRNA associated with 
the 11.8 nm pSMP was 1.29E-03 ± 2.65E-04 µm2/second.  Cap mobility of IAP84 
dsRNA associated with the 11.8 nm pSMP was 1.25E-03 ± 8.44E-05 µm2/second (Table 
2.1 and Fig. 2.3).  The cap and core measurements for each pore size were not 
significantly different for any pSMP, regardless of pore size (p-value for 3.6, 7.4, and 
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11.8 nm samples:  0.48425, 0.90234, 0.78468, respectively).  This indicates that there is a 
relationship between cap and core mobility, namely that the presence of dsRNA inside 
the particle enables movement of dsRNA on the surface of particles.  
 BIR2 Diffusivity in Different Pore Sizes of pSMPs 
 
 To further study the relationship between dsRNA length, pore size, and dsRNA 
diffusivity, BIR2 dsRNA (282 bp) was investigated.  These two lengths were chosen 
because they are the same functional domain of the IAP gene, with IAP84 residing within 
BIR2.  Fluorescently labeled BIR2 dsRNA was combined with nonporous, 3.6 nm 
porous, 7.4 nm porous, and 11.8 nm porous silica microparticles at a ratio of 0.25 mg 
dsRNA/mg pSMP.  The same FRAP experiment utilized in the IAP84 dsRNA mobility 
experiment was performed with the BIR2 dsRNA (Fig. 2.2).  BIR2 dsRNA showed no 
diffusivity, which is a direct measurement of mobility, on the cap or core of 3.6 nm 
pSMPs and on the cap of nonporous SMPs.  Core mobility of BIR2 dsRNA associated 
with the 7.4 nm pSMPs was 1.45E-04 ± 4.75E-05 µm2/second.  Cap mobility of BIR2 
dsRNA associated with 7.4 nm pSMPs was 1.69E-04 ± 5.71E-05 µm2/second.  Core 
mobility of BIR2 dsRNA associated with 11.8 nm pSMPs was 4.96E-04 ± 1.99E-04 
µm2/second.  Cap mobility of BIR2 dsRNA associated with 11.8 nm pSMPs was 4.87E-
04 ± 1.96E-04 µm2/second.  These values are recorded in Table 2.1 and Figure 2.4.  The 
cap and core measurements for each pore size were not significantly different for any 
pSMP, regardless of pore size (p-value for 7.4 and 11.8 nm samples:  0.54215 and 
0.95343, respectively).  Although mobility of BIR2 dsRNA was detected in the 7.4 nm 
and 11.8 nm pSMPs, the recorded diffusivity values are lower than the diffusivity values 
for IAP84 dsRNA (Table 2.1).  This indicates that diffusivity and dsRNA mobility 
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decreases as dsRNA length increases, suggesting that there are limits on the length of 
dsRNA that will exhibit mobility on pSMPs.   
Diffusivity of IAP84 dsRNA at Varying Concentrations in Association with 
11.8 nm pSMPs 
 
 To test the effects of dsRNA concentration on mobility, the most mobile 
dsRNA/pSMP combination, fluorescently labeled IAP84 dsRNA with 11.8 nm pSMPs, 
was tested by FRAP analyses at three concentrations:  0.25 mg dsRNA/mg 11.8 nm 
pSMPs (which is the concentration used in the previous experiment), 0.13 mg dsRNA/mg 
11.8 nm pSMPs, and 0.07 mg dsRNA/mg 11.8 nm pSMPs.  Initially, we investigated 
how different concentrations of dsRNA effected loading on the particle.  Interestingly, at 
0.07 mg/mg, only surface binding is observed and the bound dsRNA is not mobile.  
Fluorescent dsRNA is not detected inside the particle.  However, at twice this 
concentration, 0.13 mg/mg, surface binding and ubiquitous internal binding are observed.  
At four times the initial concentration, 0.25 mg/mg, strong surface binding and uniform 
internal binding are observed, as indicated by the presence and brightness of the 
fluorescent signal (Fig. 2.5). 
FRAP analyses were then used to measure dsRNA diffusivity.  As dsRNA 
concentration increased, dsRNA mobility on the surface and in the interior of 11.8 nm 
pSMPs increased (Table 2.3 and Fig. 2.6).  Cap and core mobility of IAP84 dsRNA in 
association with 11.8 nm pSMPs at a concentration of 0.07 mg dsRNA/mg pSMP was 
0.00 µm2/second.  Core mobility of IAP84 dsRNA in association with 11.8 nm pSMPs at 
a concentration of 0.13 mg dsRNA/mg pSMP was 4.02E-04 ± 2.80E-04 µm2/second.  
Cap mobility of IAP84 dsRNA in association with 11.8 nm pSMPs at a concentration of 
0.13 mg dsRNA/mg pSMP was 2.16E-04 ± 7.78E-05 µm2/second.  At the highest 
27 
 
concentration used, 0.25 mg/mg, the dsRNA was highly mobile on the cap and in the core 
of the 11.8 nm pSMPs.  The core diffusivity was 1.29E-03 ± 2.65E-04 µm2/second.  The 
cap diffusivity was 1.25E-03 ± 8.44E-05 µm2/second.  The cap and core measurements 
for samples were not statistically different (p-values for 0.13 mg/mg and 0.25 mg/mg:  
0.24571 and 0.78468, respectively).  Taken together, these results indicate that not only 
do dsRNA length and particle pore size influence mobility, but also that dsRNA mobility 
is concentration-dependent.  Thus, it is necessary to optimize dsRNA length, 
concentration, and pSMP pore size to maximize dsRNA diffusivity and thus mobility.  
 Porous silica nanoparticles are excellent candidates for dsRNA delivery to insect 
cells for several reasons.  Pore size can be easily manipulated, surface characterizations 
can be changed, they possess strong biocompatibility with cell membranes, they can be 
manipulated to hold large volumes of molecules, and they are cheap and easy to produce 
(Möller et al. 2016).  Many of these qualities can be studied in equivalent mesoporous 
silica microparticles, which are large enough to be observed with confocal microscopy.  
We began this study with the intention of characterizing the relationship between dsRNA 
size and particle pore size in relation to loading, and in turn observed dsRNA mobility.  
Using FRAP, we discovered the unique relationship between dsRNAs of different 
lengths, microparticles with different sized pores, and dsRNA concentration. 
Both pSMP pore size and dsRNA length influenced dsRNA mobility.  The shorter 
dsRNA, IAP84 (84 bp) had consistently higher mobility than the larger dsRNA, BIR2 
(282 bp).  For both dsRNA lengths, mobility increased as pore size increased and the 
mobility was not significantly different between the cap and core measurements.  In 
contrast, no diffusivity was recorded for either dsRNA length on nonporous SMPs.  This 
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suggests that it is important for a particle to contain a network of pores to serve as a 
‘sink’ to aid in dsRNA mobility on the surface of the particle.  After establishing that the 
IAP84 dsRNA was the most mobile in 11.8 nm pSMPs and was more mobile than BIR2 
dsRNA, we tested the effect that dsRNA concentration had on dsRNA mobility.  As 
dsRNA concentration increased, mobility also increased.  This suggests that dsRNA 
mobility is not only influenced by dsRNA length and pSMP pore size, but also by dsRNA 
concentration.  
 Protein delivery by silica nanoparticles is studied for applications in drug 
delivery, chemical synthesis, biosensors, and bioseparations (Schlipf et al. 2013).  The 
Schlipf et al. (2013) study utilized similar methods, namely confocal microscopy, to 
elucidate the relationship between protein molecules and mesoporous silica 
microparticles.  They discovered that, under certain conditions, enhanced green 
fluorescent protein (EGFP) molecules could be inactivated by Pepsin A when not fully 
protected by pores (Schlipf et al. 2013).  This experiment went further in studying the 
protection properties of porous microparticles and discovered that an optimal pore size 
that allows EGFP to be protected while excluding Pepsin A is possible, which lends itself 
well to the second application in our work.  Once we discovered that smaller dsRNA can 
enter pores and have high mobility, we began studying the protection properties of pores 
against degradation by RNase III (see Chapter 3).  This information is critical in 
designing particles for molecule delivery. 
 Several delivery methods for siRNAs have been researched, including polymers, 
liposomes, dendrimers, hydrogels, and inorganic host systems (Wang et al. 2010 and 
Draz et al. 2014).  One paper investigated the relationship between amine functionalized 
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porous nanoparticles and dsRNAs (Möller et al. 2016), although they used siRNAs which 
were smaller than the RNAs tested in this study.  They showed that nanoparticles with 4 
nm pores were capable of binding large amounts of siRNA, and that, through surface 
manipulation, these nanoparticles could successfully deliver their siRNA loads to 
cancerous cells.  Although Möller et al. (2016) established useful methods for 
manipulating particle pore size and surface characterization for the association of dsRNA, 
they did not investigate the diffusivity of siRNA molecules in nanoparticles.  
 In insect pest management, nanoparticle studies have focused on toxicity and 
enhancing the use of pesticides with metal nanoparticles (Afrasiabi et al. 2016;  
Kucharska et al. 2016;  Allahvaisi, 2016;  Pappas et al. 2017;  Meng et al. 2017).  It is 
important to note that numerous types of nanoparticles exist, all with their own unique 
properties.  Several articles have explored the stability of dsRNA when associated with 
different types of nanoparticles and how this effects RNAi efficacy (He at al. 2013;  
Zhang et al. 2010;  Thairu et al. 2017;  Das et al. 2015).  What these studies lack is the 
fundamental investigation into the relationship between dsRNA and nanoparticles, before 
these complexes enter insects and their cells.  That is the gap which we address with this 
study.  
 This information about how dsRNA size, dsRNA concentration, and pore size 
influence dsRNA mobility is critical to designing a nanoparticle delivery system for 
introducing dsRNA into insect cells.  Without this fundamental knowledge, nanoparticle 
delivery experiments have a high risk for failure that is not due to the efficacy of dsRNA 
but to the failure of the delivery system.  Future directions for this work are to assess in 
vitro and in vivo functionality.  Diffusivity data can be assessed in vitro by exposing 
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dsRNA/nanoparticle complexes to nucleases found in cells.  If dsRNAs are short enough 
to fully load nanoparticles and have high mobility, nanoparticles can protect dsRNA from 
degradation and the highly mobile dsRNA can leave the nanoparticle once inside insect 
cells.  This optimized system can be evaluated in insect cells.  Many assays are 
commercially available for assessing in vivo functionality, and we utilized a phenotypic 
assay that relied on nuclear staining and fluorescent microscopy of cells after being 
exposed to dsRNA/nanoparticle complexes.  
 To characterize the mobility of dsRNA in mesoporous silica microparticles, two 
dsRNA lengths and four types of silica microparticles were used.  Using confocal 
microscopy and fluorescence recovery after photobleaching, we determined that 
diffusivity was highest for IAP84 dsRNA associated with 11.8 nm pSMPs.  We then used 
different concentrations of IAP84 dsRNA in association with 11.8 nm pSMPs to establish 
the role of dsRNA molecules in dsRNA mobility.  This data provides more information 
about the design of an effective and functional nanoparticle delivery system for dsRNA 
to insect cells.  
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Figure 2.1.  Confocal Microscopy Images for all Four Microparticle Types Loaded 
with Two dsRNA Lengths.   
Confocal microscopy images for nonporous, 3.6 nm porous, 7.4 nm porous, and 11.8 nm 
mesoporous silica microparticles associated with fluorescein-12-UTP double-stranded 
RNA.  The shorter, 84 base pair dsRNA (IAP84) showed diffuse loading throughout the 
entirety of the porous microparticles and binding on the outside of the nonporous 
microparticles.  The longer, 282 base pair dsRNA (BIR2) showed diffuse binding 
throughout the 7.4 nm and 11.8 nm porous microparticles.  Only surface binding was 
observed on the nonporous and 3.6 nm porous microparticles, which means that larger 
dsRNA molecules are not capable of loading into the interior of 3.6 nm particles.  
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Table 2.1.  Diffusivity Data for IAP84 dsRNA and BIR2 dsRNA on Three Types of 
Mesoporous Silica Microparticles and Nonporous Silica Microparticles.   
 84 bp dsRNA 282 bp dsRNA 
Pore Size Cap Core Cap Core 
Nonporous 0.00 
µm2/s 
0.00 
µm2/s 
0.00 
µm2/s 
0.00 
µm2/s 
3.6 nm 2.91 E-04 
± 
5.49 E-05 
2.45 E-04 
± 
5.94 E-05 
0.00 0.00 
7.4 nm 8.26 E-04 
± 
2.66 E-04 
8.47 E-04 
± 
1.85 E-04 
1.69 E-04 
± 
5.71 E-05 
1.45 E-04 
± 
4.75 E-05 
11.8 nm 1.25 E-03 
± 
8.44 E-05 
1.29 E-03 
± 
2.65 E-04 
4.87 E-04 
± 
1.96 E-04 
4.96 E-04 
± 
1.99 E-04 
 
Diffusivity, measured in µm2/second, was not detected for the IAP84/nonporous, 
BIR2/nonporous, and BIR2/3.6 nm pSMP samples.  Diffusivity increased for both 
dsRNA lengths as pore sized increased.  IAP84 samples consistently showed higher 
diffusivity in porous microparticle samples then BIR2 dsRNA.  Cap and core diffusivity 
measurements were not significantly different.  
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Figure 2.2.  Overview of the Fluorescence Recovery After Photobleaching Process 
(FRAP) on Microparticles Already Loaded with dsRNA.   
This figure illustrates FRAP as used to assess diffusivity of dsRNA on microparticles 
already associated with dsRNA.  (A) The path of the argon laser through the mesoporous 
microparticle and the location of the particle where mobility measurements are taken.  
(B) The fluorescence intensity, representing the movement of fluorescein-12-UTP labeled 
dsRNA, at various time points:  pre-bleach, when the particle is bleached, and post-
bleach.  After approximately 40 seconds, fluorescence intensity is near to what it was 
before FRAP.  (C) A picture of a pSMP immediately after it’s been struck by an argon 
laser (left) and the same pSMP during fluorescence recovery (right).  
 
34 
 
 
Figure 2.3.  Diffusivity Results for IAP84 dsRNA in Mesoporous Silica 
Microparticles.   
Average diffusivity of IAP84 dsRNA (84 bp) in three types of porous silica 
microparticles measured by fluorescence recovery after photobleaching (FRAP).  For 
each measurement, four samples were used.  Error bars represent the standard error of 4 
samples.  Diffusivity of the dsRNA is recorded in µm2/second.  Cap and core 
measurements of diffusivity were not significantly different. 
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Figure 2.4.  Diffusivity Results for BIR2 dsRNA in Mesoporous Silica 
Microparticles.  
Average diffusivity of BIR2 dsRNA (282 bp) in three types of mesoporous silica 
microparticles measured by fluorescence recovery after photobleaching (FRAP).  For 
each measurement, four samples were used.  Error bars represent the standard error of 4 
samples.  Diffusivity of the dsRNA is recorded in µm2/second.  No diffusivity was 
measured at the cap or in the core of 3.6 nm microparticles.  Cap and core diffusivity 
were not significantly different for the 7.4 nm and 11.8 nm microparticles.  
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Table 2.2.  Primers Used for PCR and Subsequent dsRNA Synthesis.   
Primer Name Primer Sequence (5’3’) 
SfIAP_BIR2_F TAATACGACTCACTATAGCTACCTCGGCCGTAGAGATGA 
SfIAP_BIR2_R TAATACGACTCACTATAGTGCATATCGTGGGTGCACG 
SF_IAP_84_R TAATACGACTCACTATAGCTCCACTTTACAGAAAGCGC 
 
Each primer contained the T7 promoter sequence and the PCR amplification sequence (in 
bold).  BIR2 primers synthesized dsRNAs of 282 base pairs.  The IAP84 primer was used 
together with the SfIAP_BIR2_F primer and synthesized dsRNAs of 84 base pairs.  
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Figure 2.5.  Confocal Microscopy Images for Different Concentrations of IAP84 
dsRNA Associated with 11.8 nm Mesoporous Silica Microparticles.   
Confocal microscopy images for fluorescein-12-UTP labeled IAP84 dsRNA associated 
with 11.8 nm porous silica microparticles at 3 different concentrations:  0.07 mg 
dsRNA/mg pSMPs (A), 0.13 mg dsRNA/mg pSMPs (B), and 0.25 mg dsRNA/mg 
pSMPs (C).  At a dsRNA to particle ratio of 0.07 mg/mg, dsRNA was only bound to the 
borders of the particle and not the interior.  At a dsRNA to particle concentration twice 
that, 0.13 mg/mg, dsRNA loads ubiquitously but does not move well within the particles.  
At a concentration of 0.25 mg dsRNA/mg pSMPs, four times the concentration used in 
panel A, loading throughout the particle is present and the dsRNA is highly mobile.  
 
  
(C) (A) (B) 
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Table 2.3.  Diffusivity Data for IAP84 dsRNA Associated with 11.8 nm Mesoporous 
Silica Microparticles at Three Different Concentrations.   
 Diffusivity  
(µm2/second) 
Concentration (mg dsRNA/mg pSMPs) Cap Core 
0.07 0.00 0.00  
0.13 2.16E-04 
± 
7.78E-05 
4.02E-04 
± 
2.80E-04 
0.25 1.25E-03 
± 
8.44E-05 
1.29E-03 
± 
2.65E-04 
 
Diffusivity of IAP84 dsRNA associated with 11.8 nm porous microparticles was recorded 
at three different concentrations:  0.07 mg dsRNA/mg pSMPs, 0.13 mg dsRNA/mg 
pSMPs, and 0.25 mg dsRNA/mg pSMPs.  These diffusivity values were not statistically 
different between the cap and core.  No diffusivity was recorded for the 0.07 mg 
dsRNA/mg pSMP concentration.  As concentration increased, diffusivity also increased.  
Diffusivity was highest at the 0.25 mg dsRNA/mg pSMP concentration.  Measurements 
were recorded in µm2/second.  
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Figure 2.6.  Diffusivity Results for Selected Concentrations of IAP84 dsRNA in 11.8 
nm Mesoporous Silica Microparticles.   
 
Average diffusivity of IAP84 dsRNA (84 bp) in association with 11.8 nm porous silica 
microparticles at three different concentrations measured by fluorescence recovery after 
photobleaching (FRAP).  For each measurement, four samples were used.  Error bars 
represent the standard error of 4 samples.  Diffusivity of the dsRNA is recorded in 
µm2/seconds.  Diffusivity was not significantly different between cap and core 
measurements.  Diffusivity decreased as dsRNA concentration decreased, and no 
diffusivity was recorded at a dsRNA to particle ratio of 0.07 mg/mg. 
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Chapter Three:  Protection of dsRNA from RNase III by Porous and Nonporous 
Silica Nanoparticles and in vivo Applications 
INTRODUCTION 
Nanoparticle is a general term used to describe microscopic materials 10 nm to 
1000 nm in diameter.  Some classes of nanoparticles have been used to deliver molecules 
to numerous eukaryotic organisms (He et al. 2013;  Zhang et al. 2010;  Xia et al. 2009;  
Torney et al. 2007).  Their utility has been investigated for delivery of chemicals and 
biological macromolecules, as an alternative to toxic chemotherapy, and for other 
applications.  
Porous silica nanoparticles are a class of nanoparticles that provide increased 
surface area for chemical binding and, depending on pore size, may offer protection 
against degradation in cells and organisms (Möller et al. 2016).  Protecting proteins and 
nucleic acids from lytic enzymes is critical to their functional delivery for therapeutic 
purposes.  Protection of dsRNA is particularly important because of the ability of dsRNA 
to activate DICER and trigger an RNA interference (RNAi) response.  For example, in 
insects, one of the main hypotheses as to why RNAi fails in some orders of insects is that 
nucleases that are present in the gut and hemolymph degrade dsRNAs before they contact 
target cells.  Nuclease activity has been recorded in two species of lepidopterans, 
Manduca sexta and Bombyx mori.  Non-specific activity of ribonucleases was recorded in 
the hemolymph of M. sexta by Garbutt et al. (2013).  In B. mori, RNase activity was 
recorded in the digestive juices and hemolymph by Liu et al. (2012).  For RNAi to work 
efficiently, dsRNA needs to be stable and intact until it reaches its target.  One means to 
ensure dsRNA protection is to deliver dsRNAs in a nanoparticle delivery vehicle that 
protects against RNases.  Nanoparticles meet several of these requirements as a dsRNA 
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delivery vehicle, including large surface area, high dsRNA loading capacity, ease of 
adapting physicochemical properties of exterior and internal surfaces, and 
biocompatibility with cells (Möller et al. 2016).  
Mesoporous silica nanoparticles (pSNPs) protect proteins from degradation in a 
pore-size dependent manner (Schlipf et al. 2013).  By utilizing the fluorescence of 
enhanced green fluorescent protein (EGFP), the researchers identified the properties of 
mesoporous silica particles that protect EGFP from proteolysis by Pepsin A.  Because 
EGFP has a diameter of 2.4 nm x 4.2 nm and Pepsin A has a diameter of 7.3 nm x 3.6 
nm, they concluded that tailored pores could efficiently load EGFP while excluding 
Pepsin A, thus protecting EGFP from proteolysis, in a pore size-dependent manner.  
Because the globular structure of proteins and the predominantly linear structure of 
dsRNA differs significantly, this work utilized a similar approach to investigate whether 
pSNP pores can protect dsRNAs from RNases.   
While the ability of some nanoparticles to protect dsRNA from digestion has been 
studied in mammalian systems, the protection qualities of nanoparticles in insect cells 
have yet to be studied.  Zhang et al. (2010) and He et al. (2013) report that 
dsRNA/nanoparticle complexes can weaken insects, making them more susceptible to 
insecticide treatments and reducing resistance to insecticides.  However, these researchers 
did not study in vitro relationships between dsRNA and nanoparticles before feeding the 
complexes to insects.  Thus, a gap exists in our basic knowledge and applied technologies 
relevant to the design and use of nanoparticles for insect control.   
If pSNPs that protect dsRNAs from nuclease degradation are identified, there are 
other requirements for efficacious use of these nanoparticle/dsRNA complexes for insect 
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control.  The dsRNA/pSNP complexes must be taken up by insect cells and activate 
RNAi responses in insect cells and insects.  A common assay for efficacious dsRNA 
delivery to cells and organisms is to target expression of genes that inhibit apoptosis.  
Inhibiting such genes, such as the Inhibitor of Apoptosis (IAP), activates apoptosis in 
cells, which is evident by cell lysis and associated cellular processes such as DNA 
fragmentation.  Apoptosis assays in several forms are commercially available and include 
cell death detection by ELISA, Annexin V assays that rely on the staining of 
phosphatidylserine, and nuclear dyes to observe the structure of the nucleus.  We 
assessed apoptotic responses by live cell imaging in combination with fluorescent 
microscopy to observe if nuclear changes indicating apoptosis were induced by 
pSNP/IAP dsRNA complexes in this study.  
 
MATERIALS AND METHODS 
Cell Culture 
Sf9 cells were cultured in Sf-900 II serum-free media (GibcoTM Cell Culture) per 
established protocols (O’Reilly et al. 1994).  Cells were maintained and passaged as 
adherent monolayer cultures in 25 cm2 tissue-culture flasks or as shaker flasks in 125 mL 
polycarbonate Erlenmeyer flasks with vent caps (Corning, Corning, NY) at 32°C.  Cell 
density and viability was determined using a Trypan Blue dye exclusion assay and a 
hemocytometer. 
Synthesis of dsRNA 
 
Sf9 DNA was extracted from cultured cells using phenol-chloroform extraction.  
This DNA was then used in PCR to amplify selected functional domains of the Inhibitor 
of Apoptosis (IAP) gene.  To synthesize dsRNAs of three lengths, segments of the 
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Spodoptera frugiperda IAP gene (GenBank: AF186378.1) were amplified with the PCR 
and IAP sequence specific primers that also contained T7 promoters.  Three dsRNAs 
were then synthesized from the PCR template DNA by in vitro transcription.  Table 3.1 
shows primers used to amplify three segments of the IAP gene:  IAP84 (84 base pairs 
[bp]), really interesting new gene (RING) (184 bp), and second baculovirus IAP repeat 
(BIR2) (282 bp) (Borden and Freemont, 1996).  Both RING and BIR2 are functional 
domains within the coding sequence of the IAP gene identified by Huang et al. (2000).  
IAP84 resides within BIR2.  Each 25 µL PCR reaction was prepared at room temperature 
and contained the following:  2.5 µL10X PCR buffer, 1.5 µL MgCl2 (50 mM), 2.0 µL 
dNTP mix (10 mM), 0.5 µL forward primer (100 mM), 0.5 µL reverse primer (100 mM), 
0.25 µL Taq Polymerase (Invitrogen, Waltham, MA), 1 µL Sf9 DNA, and 16.75 µL 
nuclease-free H2O.  PCR reactions were run on a PTC-200 DNA Engine (Bio-Rad, 
Hercules, CA) with the following cycling parameters:  initial denaturation at 95°C for 30 
sec, followed by 30 cycles of denaturation at 95°C for 30 sec, annealing at 58°C for 30 
sec, and extension at 68°C for 30 sec, and a final extension incubation at 68°C for 5 min.  
Five µL of each PCR product was analyzed on a 1.75% agarose gel to confirm 
that amplicons were of the designed product length.  For dsRNA synthesis, PCR products 
for IAP84 and BIR2 were purified using the Fermentas GeneJET PCR Purification Kit 
(Fermentas, Waltham, MA) per the manufacturer’s protocol.  The RING PCR product 
was excised from the gel with a razor blade and purified from the excised band using the 
Qiagen QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany). 
Fluorescently labeled BIR2 and IAP84 dsRNA was synthesized using the 
HiScribe T7 High Yield RNA Synthesis Kit (New England Biolabs, Ipswich, MA).  The 
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reaction mixture was prepared at room temperature and contained the following:  2.0 µL 
10X T7 reaction buffer, 2.0 µL ATP (100 mM), 2.0 µL GTP (100 mM), 2.0 µL CTP (100 
mM), 1.5 µL UTP (100 mM), 0.5 µL fluorescein-12-UTP (250 nmol, Roche, Basel, 
Switzerland), approximately 10 ng purified PCR product template, 2.0 µL T7 RNA 
polymerase mix, and nuclease-free H2O.  The final volume was 20 µL.  Samples were 
vortexed and incubated at 37°C overnight.  Fluorescently labeled RING dsRNA was 
prepared in the same manner, except that purified PCR samples were first heated to 65°C 
and cooled to 42°C, after which 8 µL was added to each reaction mixture.  Non-
fluorescently labeled RING dsRNA was made with the same HiScribe T7 High Yield 
RNA Synthesis Kit (New England Biolabs, Ipswich, MA) and PCR template.  The 
reaction mixture was prepared at room temperature and contained the following:  2.0 µL 
10X T7 reaction buffer, 2.0 µL ATP (mM), 2.0 µL GTP (100 mM), 2.0 µL CTP (100 
mM), 2.0 µL UTP (100 mM), 2.0 µL T7 RNA polymerase mix, and nuclease-free H2O.  
Approximately 10 ng of purified RING PCR template was first heated to 65°C and 
cooled to 42°C, after which 8 µL was added was added to the reaction mixture.  The 
mixture was vortexed and incubated at 37°C overnight.  
 After incubation, newly synthesized dsRNA samples were quantified on a 
NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA) and then 
diluted 1:4 in nuclease-free H2O.  7.2 µg of each diluted sample was combined with 
nuclease-free H2O for a total volume of 31 µL.  Size and purity of dsRNA samples were 
verified on 2% agarose gels. 
 Mesoporous Silica Nanoparticle Solutions 
Mesoporous silica nanoparticles (pSNPs) were synthesized and provided by M. 
Arif Khan in the lab of Dr. Barbara Knutson and Dr. Steve Rankin.  Details of pSNP 
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synthesis are provided elsewhere (Appendix B).  Nonporous silica nanoparticles were 
synthesized per methods established by Bogush et al. (1988).  Mesoporous silica 
nanoparticles (pSNPs) with an average pore size diameter of 2.20 ± 0.16 nm (referred to 
as 2.7 nm pSNPs) were synthesized using a modified Stöber method (Kim et al. 2010).  
pSNPs with an average pore size diameter of 4.10 ± 0.35 nm (referred to as 4.5 nm 
pSNPs) were synthesized per methods established in Gu et al. (2013).  pSNPs with an 
average pore size diameter of 7.90 ± 2.15 nm (referred to as 8.0 nm pSNPs) were 
synthesized using a modified version of methods established by Yamada et al. (2015).  
Particle names represent the pore sizes before amine functionalization.  After synthesis, 
all four types of nanoparticles were amine functionalized by condensing (3-
Aminopropyl)triethoxysilane (APTES) onto the particle surface, per modified methods 
established in Ezzeddine et al. (2015) and Na et al. (2012).  Pore size after amine 
functionalization for 2.7 nm, 4.5 nm, and 8.0 nm pSNPs was 1.58 ± 0.14 nm, 3.24 ± 0.38 
nm, and 7.55 ± 1.92 nm, respectively.  Pore size values represent average pore size 
estimated by the method of Barrett, Joyner, and Halenda (BJH).  The BJH method has 
some inherent error that often underestimates pore size by 0.5 nm due to assumptions 
(Ravikovitch et al. 2001).  Morphology and shape of functionalized and 
nonfunctionalized particles were characterized using a Hitachi S-4300 Scanning Electron 
Microscope (Hitachi High-Technologies Corporation, Japan).  Average pore diameter, 
pore size distribution, and surface area were estimated from nitrogen sorption conducted 
at 77 K using a Micromeritics TriStar 300 (Micromeritics Instrument Corporation. 
Norcross, GA).  
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Nanoparticle stock solutions were made up in concentrations of 10 mg/mL stock 
solution in nuclease-free H2O.  Before being used, pSNP solutions were sonicated using a 
Tekmar Sonic Disruptor for 15 seconds (Teledyne Tekmar, Mason, OH) to suspend the 
particles in solution.  After the initial sonication, all pSNP solutions were vortexed with a 
Vortex Genie 2 (Thermo Fisher Scientific, Waltham, MA) for 15 seconds immediately 
before being used. 
RNase III Digest  
To assess the ability of pSNPs to protect dsRNA from digestion by RNase III, 7.2 
µg of fluorescently labeled dsRNA was combined with 100 µg of non-FITC labeled, 
amine functionalized silica nanoparticles.  The treatment groups were as follows:  dsRNA 
and 8.0 nm pSNPs, dsRNA and 4.5 nm pSNPs, dsRNA and 2.7 nm pSNPs, dsRNA and 
nonporous SNPs, dsRNA and RNase III (positive control), and dsRNA only (no RNase, 
negative control).  Samples were vortexed and shaken on a 55S 12 x 16 Single Platform 
Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at room temperature for 
one hour to allow for dsRNA attachment.  The dsRNA from the negative and positive 
control samples were also shaken on a 55S 12 x 16 Single Platform Laboratory Shaker 
(Reliable Scientific, Nesbit, MS) for one hour.  Three units of ShortCut RNase III (New 
England Biolabs- M0245S), 3 µL of 10X ShortCut Reaction Buffer, 3 µL of 10X MnCl2 
(200 mM), and nuclease-free H2O to 25 µL were added to each sample.  The negative 
control sample received nuclease-free H2O to 25 µL.  Samples were then vortexed for 15 
seconds (Thermo Fisher Scientific, Waltham, MA) and incubated at 37°C for either 15, 
30, or 60 minutes.  After incubation, 5 µL of 10X EDTA (500 mM) was added to the 
solution to inactivate the RNase III.  To promote dissociation of the dsRNA from the 
nanoparticles, 1 µL of heparin sodium solution (1 µg/µL in nuclease free H2O;  Avantor 
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Performance Materials, Center Valley, PA) was added to each sample and vortexed.  All 
solutions except the heparin solution and nuclease-free H2O were provided in the 
ShortCut RNase III kit (New England Biolabs, Ipswich, MA).  
To assess dsRNA degradation, 5 µL of each sample was run on a 2.0% agarose 
gel in 1X sterile TBE buffer.  Initially the gel tank was filled with 1X sterile TBE buffer 
so that the buffer was touching the gel but not covering it.  Samples were loaded into the 
dry wells and allowed to run for approximately 5 minutes at 75 volts, after which the gel 
was covered with 1X sterile TBE buffer and run at 48 volts for 2.5 hours.  Dry loading 
the wells was done to prevent sample contamination between wells.  Images were taken 
on an Alpha Innotech Alpha Imager 2200 Gel Documentation Cabinet & 
Transilluminator (Alpha Innotech, San Leandro, CA).  
Fluorescence Exchange on Saturated Particles 
Another key factor required for an efficient dsRNA delivery vehicle is the ability 
to release the dsRNA from particles once the complex enters insect cells.  To assess this 
capability, we saturated large microparticles with a pore size of 11.8 nm with non-
fluorescently labeled IAP84 dsRNA at a concentration of 0.25 mg dsRNA/mg particles.  
Excess dsRNA was removed from the solution by pelleting the dsRNA/microparticle 
complexes, removing approximately 95% of the solution, and replacing the removed 
solution with nuclease free H2O.  After washing, an equivalent amount of fluorescently 
labeled IAP84 was added to the solution.  Fluorescent exchange was monitored after 10 
minutes and 40 minutes with a Leica TCS SP5 Confocal Microscope (Leica 
Microsystems, Wetzlar, Germany).  
Cell Viability Assay 
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To establish that in vitro relationships between dsRNA and pSNPs were valid for 
cellular analyses, we used fluorescent microscopy and nuclear staining to determine 
nuclear structure after several apoptotic-inducing and control treatments.  Sf9 cells from 
shaker flasks were seeded at a density of 1.0x106 cells (0.45 mL total volume/treatment) 
and then exposed to seven different treatment groups:  cells only, cells + pSNPs, RING 
dsRNA only, RING + pSNPs, EYFP dsRNA only, EYFP + pSNPs, and camptothecin.  
The working volume for all samples was 450 µL.  In “dsRNA Only” treatments, 3.0 µg 
of RING dsRNA (184 bp) or EYFP dsRNA (170 bp) were placed directly into Sf-900 II 
serum-free media (GibcoTM Cell Culture).  In the “cells + pSNPs” sample, 50 µg of 
FITC-labeled 8 nm pSNPs were added to Sf-900 II serum-free media.  In “dsRNA + 
pSNP” samples, 3.0 µg of the respective dsRNA and 50 µL of pSNP stock solution were 
placed in a 0.6 mL microcentrifuge tube together, and then shaken for one hour on a 55S 
12 x 16 Single Platform Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at 
room temperature for dsRNA attachment to pSNPs.  Once dsRNA/pSNP complexes had 
formed, cell density was calculated using a Trypan Blue exclusion assay and a 
hemocytometer.  One million cells were placed in each microcentrifuge tube and Sf-900 
II serum-free media was added to make a working volume of 450 µL.  The positive 
control, the camptothecin sample, was also prepared at that time by combining 50 µL of 
100 mM camptothecin with one million cells in a total volume of 450 µL.  All samples 
were then shaken on a 55S 12 x 16 Single Platform Laboratory Shaker (Reliable 
Scientific, Nesbit, MS) at 40 rpm at room temperature for 30 minutes to facilitate cell 
uptake of dsRNA/pSNP complexes.  After 30 minutes, one drop of NucBlueTM Live 
ReadyProbesTM Reagent was added to each sample to stain the nuclei (Thermo Fisher 
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Scientific, Waltham, MA).  The sample tubes were wrapped in foil and shaken on a 55S 
12 x 16 Single Platform Laboratory Shaker (Reliable Scientific, Nesbit, MS) at 40 rpm at 
room temperature for 20 additional minutes.  After the final shaking, samples were 
transferred to a labeled 48 well plate (Corning, Corning, NY) and incubated at 30°C for 
12 hours.  Samples were imaged on an Olympus IX71 fluorescent microscope (Olympus 
Corportation, Tokyo, Japan).  
 
RESULTS AND DISCUSSION 
 To optimally design nanoparticles for use as a dsRNA delivery system, it is 
necessary to understand their physicochemical properties and interactions with dsRNA.  
This study investigated two aspects of these interactions in vitro:  the binding of dsRNA 
to and its mobility on pSMPs and the protection of bound dsRNA from RNase digestion 
when bound to pSMPs.  An important assumption of this work is that pSMPs are an 
appropriate model for pSNP interactions with dsRNA.  For RNA silencing to be induced, 
dsRNAs must be protected from nuclease digestion long enough to enter insect cells, and 
the dsRNA must be released from the particle to induce an RNAi response.  Both loading 
and release of dsRNA from pSMPs necessarily requires some mobility of the RNA on the 
particle.  This study investigated the relationship between dsRNA length and pore size in 
relation to nuclease degradation, by utilizing fluorescently labeled dsRNA of three sizes 
(282 bp, 184 bp, and 82 bp) and four types of silica nanoparticles (nonporous, 2.7 nm, 4.5 
nm, and 8.0 nm porous).  A prior study (Chapter 2) showed pronounced differences in 
mobility of the 282 and 84 bp RNAs in that the larger RNA showed no mobility while the 
smaller RNA was highly mobile.  In this study, we also test an intermediate size RNA of 
184 bp that is an amplimer of a section of the RNA that encodes a functional domain of 
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the IAP protein, the RING domain.  After identifying a combination of RNA and pore 
sizes providing optimal protection of the RNA from nucleases, a fluorescence exchange 
experiment showed that dsRNA binding was reversible (Figure 3.4).  This dsRNA 
exchange experiment saturated the particle with unlabeled dsRNA and then exposed 
these ‘loaded’ particles to a solution containing the same concentration of fluorescently 
labeled dsRNA.  Exchange of the RNA would be indicated by particles which acquired 
the fluorescent label and thus dsRNA from the solution.  Taken together, the results of 
this study begin to delineate features of pSMP and dsRNA interactions that can be 
controlled and optimized for both protecting the dsRNA from degradation and enhancing 
mobility of the dsRNA on the particle.  Finally, this system was tested in insect cells for 
its ability to induce apoptosis as indicated by the nuclear condensation, nuclear 
fragmentation, and cell membrane changes that occur during apoptosis.  
BIR2 Digestion Results  
 
To evaluate the ability of pSNPs to protect dsRNA from nuclease degradation, 7.2 
µg of fluorescently labeled BIR2 282 base pair (bp) dsRNA was associated with four 
types of pSNPs (nonporous, 2.7 nm, 4.5 nm, and 8 nm porous) and then digested for 15, 
30, or 60 minutes.  Digestion for 15 minutes was insufficient to completely digest dsRNA 
in any treatment (Figure 3.1, lane 6) represented by the presence of diffusing staining.  
Diffuse staining is the term used to describe partially degraded RNA, which is 282 bp and 
less, but with no sharp, intact band of 282 bp.  After digestion for 15 minutes, low 
molecular weight, diffuse staining was present for all four types of particles.  There was 
no evidence that nonporous particles protected this dsRNA from digestion as there was 
no high molecular weight staining (~282 bp) at any timepoint.  Although all lanes in all 
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timepoints exposed to the RNase exhibited low molecular weight, diffuse bands, which is 
a result of RNA degradation, there was an increase in the amount of high-molecular 
weight staining, which is indicative of protection from RNase digestion, in treatments 
with larger pore sizes (4.5 and 8.0 nm) and shorter time points.  However, the data 
indicates that this length of RNA was susceptible to digestion at all time-points and with 
all pSNP treatments, as the intact 282 bp BIR2 dsRNA band is missing in all these 
experimental lanes.  The high molecular weight staining is indicative of only partial 
protection of the RNA from digestion by RNase.  This information, summarized in Table 
3.2 and Figure 3.1, leads to the conclusion that the BIR2 dsRNA may be too large at 282 
bp to enter the pores of nanoparticles and be fully protected from degradation.  Full 
protection would result in bands of the same size as the negative control (no RNase).  
Because of these results, a smaller dsRNA of 184 bp was chosen to repeat the 
experiment.  
RING Digestion Results 
 
Because the 282 bp dsRNA was not fully protected by any of the nanoparticle 
types, we chose to use a shorter dsRNA of 184 bp to repeat the experiment.  7.2 µg of 
fluorescently labeled, 184 bp RING dsRNA was combined with 100 µg of non-FITC 
labeled silica nanoparticles.  The dsRNA/pSNP complexes were then exposed to three 
units of RNase III.  A 15-minute digestion was not enough to fully digest the RING 
dsRNA in any treatment (Fig. 3.2 lane 6).  A large portion of the dsRNA was digested 
because there is a 20-25 bp band at the bottom of this lane.  There was no evidence that 
nonporous or 2.7 nm porous particles protected this, or any length of dsRNA, because 
there is no high molecular weight (~184 bp) staining present in these samples.  All lanes 
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exposed to RNase III exhibited low molecular weight, diffuse bands, which is a result of 
RNase degradation.  An increase in the amount of high molecular weight staining, which 
is representative of intact dsRNA, increased as pore size increased (4.5 and 8.0 nm) and 
as digestion time decreased.  This data indicates that intermediate dsRNAs, (184 bp) are 
less susceptible to degradation than large dsRNAs (282 bp) because there is more high 
molecular weight staining present in the intermediate dsRNA samples.  This information, 
summarized in Table 3.2, in combination with the BIR2 digestion data, lead us to the 
conclusion that the intermediate length dsRNA is likely more capable of entering large 
pores than larger dsRNA, but that it is still too large to be fully protected.  Because this 
information showed us that shorter dsRNAs can be better protected by certain pore sizes 
but not entirely, we then chose a smaller dsRNA to repeat the experiment.  
IAP84 Digestion Results  
 
Because of the results of the BIR2 and RING digestion studies, one would expect 
that dsRNAs of smaller lengths would more freely enter pSNPs and thus be better 
protected from RNase III digestion than dsRNAs of larger sizes.  To investigate this 
possibility, 7.2 µg of IAP84 dsRNA (84 bp) was associated with 100 µg of four types of 
silica nanoparticles and then progressively digested under increasingly stringent 
conditions.  After digestion for 15 minutes, partially degraded dsRNA, as indicated by 
low molecular weight (less than 82 bp), diffuse staining is present (Fig. 3.3) but this 
digestion time was insufficient to completely digest dsRNA in any treatment.  There was 
no evidence that nonporous or 2.7 nm porous particles protected this dsRNA from 
degradation at any time point, as there is no high molecular weight (82 bp) staining 
present in these samples.  In contrast, high molecular weight staining is present at all time 
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points in the 4.5 and 8.0 nm samples.  These observations indicate that the 84 bp dsRNA 
can enter the 8.0 and 4.5 nm pores and be protected for long periods of time but are still 
large too large to enter 2.7 nm pores.  In contrast, the 184 bp dsRNA can only be 
protected when associated with 8.0 nm pSNPs and the BIR2 dsRNA cannot be protected 
under any of the experimental conditions (Table 3.2).  This information is valuable for 
choosing the best combination of dsRNA and pSNP for dsRNA delivery to cells because 
if the chosen length of RNA is too large to enter pores and be protected, the RNA will be 
degraded before it enters target cells.  
Fluorescence Exchange on Saturated Microparticles Results 
 
Once parameters where dsRNA was protected from nuclease digestion and mobile 
as indicated by FRAP analyses, an experiment was performed to evaluate whether 
dsRNA molecules could be released from such particles and whether RNAs could be 
taken up by these particles from the environment.  That is, whether dsRNAs associated 
with porous silica microparticles (pSMPs) can be exchanged with unbound dsRNAs in 
solution.  Release of dsRNAs from nanoparticles may be required to efficiently activate 
RNAi responses.  To investigate this, pSMP/dsRNA complexes having physicochemical 
properties conducive to RNA protection and mobility were assessed and tracked by 
fluorescent confocal microscopy.  First, pSMPs with 11.8 nm pores were saturated with 
non-fluorescently labeled IAP84 dsRNA at a concentration of 0.25 mg dsRNA/mg 
pSMPs.  Because there is no fluorescent marker on this dsRNA, the confocal microscope 
only registers a black image (Fig. 3.4).  Then we added an equivalent volume of 
fluorescently labeled IAP84 dsRNA to the solution and tracked the presence of the label 
on the microparticles.  We observed that after only 10 minutes, the fluorescently labeled 
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IAP84 dsRNA was loading onto the microparticles (Fig. 3.4, panel A).  After 40 minutes, 
the fluorescence intensity had increased, indicating that more fluorescent dsRNA 
molecules were binding to the microparticles (Fig. 3.4, panel B).  This suggests that the 
binding of dsRNA to porous particles is fluid, occurs quickly, and that dsRNA binding to 
particles is reversible.  This observation is important because the dsRNA must be 
released into the target environment once it’s been delivered.  
Cell Apoptosis Results 
 
As the 8.0 nm pSNPs protected the RING and IAP84 dsRNA better than other 
tested pSNPs and better than the larger dsRNAs, an in vivo assay for assessing the ability 
of RING/8.0 nm pSNP complexes to cause apoptosis in Sf9 cells was performed.  
Importantly, this assay directly tested if this dsRNA/pSNP complex functionally activates 
an effective RNAi response.  Apoptosis is a characteristic physiological response that 
cells experience when the genes regulating apoptosis are knocked down, which results in 
nuclear condensation, nuclear fragmentation, and cell debris.  Healthy, non-apoptotic 
cells contain round, uniform nuclei (Fig. 3.5 panel A).  Cells treated with a known 
apoptosis inducing drug, camptothecin, contain nuclei that are condensing, fragmenting 
and distorted, and cell membranes that are budding (Fig. 3.5 panel C).  The first step in 
establishing if nanoparticles could efficiently deliver IAP dsRNA without causing 
indirect apoptosis was to incubate cells with nanoparticles and observe their nuclei.  Cells 
treated with only 8 nm pSNPs (Fig. 3.5 panel B) showed round, uniform nuclei, intact 
cell membranes, and fluorescently labeled nanoparticles within cell membranes when 
observed with a FITC laser.  These data indicate that nanoparticles are not contributing to 
an apoptotic response. 
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After 12 hours, IAP dsRNA/pSNP complexes are still retained by cells but their 
nuclei begin to fragment and condense (Fig. 3.5, panel E).  Cells only exposed to IAP 
dsRNA (panel D) appear to be healthy because their nuclei are generally round and non-
fragmented.  This indicates that the dsRNA alone is insufficient to cause an apoptosis 
response, which is a phenomenon that has been previously recorded by many groups and 
is summarized in Terenius et al. (2011).  
One important distinction is that the dsRNA delivered to cells by pSNPs is 
causing a gene-specific response, instead of a general apoptotic response to any 
dsRNA/pSNP complex.  For this reason, enhanced yellow fluorescent protein (EYFP) 
dsRNA was selected as an exogenous control.  When cells are exposed to unbound EYFP 
dsRNA, most cells have nuclei that are equivalent to the nuclei in the negative control 
(Fig. 3.5, panel F compared to panel A), which is indicative of healthy, non-apoptotic 
cells.  When cells are exposed to EYFP/pSNP complexes, no apoptotic phenotypes are 
observed (panel G).  This data is indicative of the apoptotic response not being caused by 
the nanoparticles or dsRNA alone, and that the apoptotic phenotype is dsRNA specific.  
Although the data needs to be replicated further, this data provides crucial in vivo 
verification of the validity of a nanoparticle delivery vehicle.  
 Protective properties of nanoparticles are influenced by dsRNA length, pore size, 
and digestion time.  Nonporous nanoparticles exhibited no protection against RNase 
digestion at any length after a one hour digestion, but there was evidence of some 
protection to RING (184 bp) and BIR2 (282 bp) fragments at the 30-minute and 15-
minute time points.  They provided no protection at any time point to the IAP84 dsRNA 
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(84 bp).  Because dsRNA has no way to enter the nanoparticles, the dsRNA molecules 
are more exposed to degradation by RNase III.  
Nanoparticles having 2.7 nm pores did not completely protect any of the tested 
dsRNA fragments after one hour of digestion, but the smaller dsRNA (IAP84) was only 
partially degraded in comparison to the larger dsRNAs (RING and BIR2) being 
completely digested.  These results are consistent with our diffusivity experiments (see 
Chapter 2), namely that larger dsRNA molecules are not able to penetrate small pore 
sizes and are thus susceptible to degradation.  Our earlier experiments also showed that 
diffusivity decreased as dsRNA size increased.  The inability of the dsRNA to move over 
the surface and inside the pSNPs likely makes it more susceptible to degradation because 
dsRNA molecules are effectively exposed at their surface binding sites. 
 For all three dsRNA lengths and time points, the 4.5 nm porous and 8 nm porous 
nanoparticles provided the most protection.  The 4.5 nm pores are probably large enough 
to allow the dsRNA to enter the nanoparticle, but not large enough to allow the RNase III 
into the particle.  ShortCut RNase III is an enzyme derived from an E. coli that contains 
the E. coli RNase III gene (rnc) and the gene coding for the maltose binding protein 
(MBP) that weighs 67591 Daltons (Product Datasheet, New England Biolabs, Ipswich, 
MA).  Although the exact dimensions of the enzyme are unknown, serum albumin is a 
globular protein weighing 66400 Da with dimensions (nm) of 7.5 x 6.5 x 4.0 (Erickson, 
2009).  Because RNase III is a globular protein having a similar weight, it will likely 
have similar dimensions to serum albumin, although the exact dimensions for this 
product have not been investigated.  At a size of 7.5 nm x 6.5 nm x 4.0 nm, the RNase III 
would not be able to enter the 4.5 nm pores, thereby protecting dsRNA that is inside the 
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particle.  Although RNase III may be small enough to enter the 8 nm pores, not all of the 
nanoparticles in the 8 nm pSNP sample have pores of exactly 8 nm.  When the 
nanoparticles are synthesized, their pore sizes vary with a mean pore size of 8 nm.  Thus, 
a large portion of the dsRNA is protected because many of the nanoparticle pores will be 
at 8 nm or smaller.  
 Our results suggest that both pore size and dsRNA length play critical roles in 
protecting dsRNA from digestion by RNase III.  Two similar studies recognized the 
importance of pore size, but did not address dsRNA length (Na et al. 2012 and Kim et al. 
2016).  Na et al. (2012) used two pore sizes:  2 nm and 23 nm, and one undisclosed 
length of dsRNA for their protection assays.  This large disparity in pore sizes makes it 
difficult to make any robust conclusions regarding the effect of pore size on dsRNA 
protection. 
 Kim et al. (2016) used a wider range of pore sizes, but the size of the dsRNA in 
their experiment was undisclosed.  From my work, it is evident that as little as a 98 bp 
difference in dsRNA size can make a substantial difference in the degree of protection.  
Thus, optimizing dsRNA protection is a function of both pore size and dsRNA length.  A 
porous nanoparticle will not protect a dsRNA that is too large to properly enter that 
nanoparticle’s pores.  However, if the pore size is too large, it will not exclude RNase 
enzymes, and thus dsRNA inside the particle is not protected.  Furthermore, the synthesis 
process of porous nanoparticles becomes increasingly difficult as pore size increases (B. 
Knutson, personal communication), because it is difficult to fit larger pores onto the same 
size nanoparticle surface.  If large pores, like the ones used by Na et al. (2012) and Kim 
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et al. (2016), are too difficult to create, dsRNA length could also be manipulated to 
enhance protection.  
 For a nanoparticle delivery vehicle to be effective, two things need to occur:  
reversible binding of dsRNA and in vivo functionality.  By using fluorescent tracking in 
mesoporous silica microparticles with equivalent physicochemical properties, we showed 
that dsRNA binding is fluid and reversible.  With the use of nucleic dye, it was concluded 
that apoptosis can be induced in Sf9 cells when IAP dsRNA is delivered by 
nanoparticles.  It was also established that nanoparticles alone and exogenous 
dsRNA/pSNP complexes do not cause apoptosis in insect cells.  Although apoptotic work 
in insect cells has not been conducted on a pSNP/dsRNA system, knockdown 
experiments have been performed in HeLa cells (Na et al. 2012).  They found that larger, 
23 nm pores can deliver small interfering green fluorescent protein (GFP) RNAs to HeLa 
cells and extinguish GFP signals.  My research aimed to take in vivo applications beyond 
weakening insecticide resistance and diminishing fluorescent proteins, and because of the 
images captured on fluorescent microscopy, we now have preliminary findings that 
support the efficacy of nanoparticle delivery systems to insect cells.  
 Three lengths of dsRNA and four nanoparticle types were used to characterize the 
protection properties of porous and nonporous silica nanoparticles against nuclease 
degradation.  I sought to understand how dsRNA length and pore size affected the 
digestion of dsRNA when in the presence of RNase III.  Although similar experiments 
have been conducted, this is the first experiment where dsRNAs length and nanoparticle 
pore size were both systematically varied in a factorial design.  My results show that 
dsRNA molecules 184 bp or less can be protected by either 4.5 nm pSNPs or 8 nm 
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pSNPs, but the best protection is provided by 8 nm pSNPs to short dsRNAs.  A saturation 
experiment with 11.8 nm porous silica microparticles and 84 bp dsRNA revealed that 
dsRNA binding to microparticles is fluid, and that dsRNA is highly mobile.  When 184 
bp IAP dsRNA is combined with 8.0 nm pSNPs, there is an apoptotic response observed 
in Sf9 cells exposed to these complexes.  The apoptosis phenotype is gene specific.  
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Table 3.1.  Primers Used for PCR and Subsequent dsRNA Synthesis.   
Primer Name Primer Sequence (5’3’) 
SfIAP_BIR2_F TAATACGACTCACTATAGCTACCTCGGCCGTAGAGATGA 
SfIAP_BIR2_R TAATACGACTCACTATAGTGCATATCGTGGGTGCACG 
SfIAP_RING_F TAATACGACTCACTATAGGTGTTTTTATTGCGATGGTGG 
SfIAP_RING_R TAATACGACTCACTATAGCCTCACAAGCTTCAGAAAT 
SfIAP_84_R TAATACGACTCACTATAGCTCCACTTTACAGAAAGCGC 
 
For each primer, the T7 promoter sequence is at the beginning of the sequence and the 
portion in bold is from the Spdoptera frugiperda Inhibitor of Apoptosis (IAP) gene.  
SfIAP_BIR2 primers were used to synthesize 282 base pair (bp) segments.  SfIAP_RING 
primers were used to synthesize 184 bp segment.  SfIAP_84_R is used with 
SfIAP_BIR2_F to amplify the 84 bp segment IAP84.   
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Figure 3.1.  Digestion of BIR2 dsRNA in the Presence and Absence of Porous and 
Nonporous Silica Nanoparticles.   
Results for 15, 30, and 60 minute digestions are shown for BIR2 dsRNA (282 bp).  
Samples containing only dsRNA are listed as “RNA Only”.  “N.P.” denotes samples with 
nonporous nanoparticles.  All samples containing RNase III are indicated by a “+”.  The 
presence of undegraded dsRNA is evident in RNA only in lanes (7, 14, and 21) and 
increases as pore size increased and as digestion time decreased.  4.5 nm porous 
nanoparticles and 8 nm porous nanoparticles provided some protection at all three time 
points (lanes 2, 3, 9, 10, 16, and 17).  Partially digested dsRNA, indicated by the presence 
of diffuse staining of ~100 bp, was evident with the 2.7 nm porous nanoparticle samples 
after 15 min digestion (lane 4).  
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Figure 3.2.  Digestion of RING dsRNA in the Presence and Absence of Porous and 
Nonporous Silica Nanoparticles.   
Results for 15, 30, and 60 minute digestions are shown for RING dsRNA (184 bp).  
Samples containing only dsRNA are indicated by “RNA Only”.  “N.P.” denotes samples 
with nonporous nanoparticles.  Samples containing RNase III are indicated by a “+”.  
Undegraded dsRNA is evident in “RNA Only” control lanes (lanes 7, 14, and 21).  
dsRNA protection increased as pore size increased and as digestion time decreased.  4.5 
nm porous nanoparticles and 8 nm porous nanoparticles provided protection at all three 
time points (lanes 2, 3, 9, 10, 16, and 17).  8 nm porous nanoparticles provided the most 
protection of all nanoparticle types (lanes 2, 9, and 16), which is indicated by a dark, 
undigested band the same length as the negative controls.  Partially digested dsRNA, 
indicated by the presence of low molecular weight, diffuse staining of ~75 bp, was 
evident with the 2.7 nm porous nanoparticle samples after 15 and 30 minute digestions 
(lanes 4 and 11).  
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Figure 3.3.  Digestion of IAP84 dsRNA in the Presence and Absence of Porous and 
Nonporous Silica Nanoparticles.   
Results for 15, 30, and 60 minute digestions are shown for IAP84 dsRNA (84 bp).  
Samples containing only dsRNA are listed as “RNA Only”.  “N.P.” denotes samples with 
nonporous nanoparticles.  All samples containing RNase III are indicated by a “+”.  The 
presence of undegraded dsRNA is evident in “RNA Only” lanes (7, 14, and 21) and 
increases as pore size increased and as digestion time decreased.  4.5 nm porous 
nanoparticles and 8 nm porous nanoparticles provided protection at all three time points 
(lanes 2, 3, 9, 10, 16, and 17), which is indicated by the presence of high molecular 
weight (84 bp) bands.  Partially digested dsRNA, indicated by the presence of low 
molecular weight, diffuse staining of ~50 bp, was evident with the 2.7 nm porous 
nanoparticle samples after 15 and 30 minute digestions (lanes 4 and 11).  
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Table 3.2.  Summary of RNase Protection from the Gels Featured Above. 
 15 Minutes 30 Minutes 60 Minutes 
 8 
nm 
4.5 
nm 
2.7 
nm 
N.P. 8 
nm 
4.5 
nm 
2.7 
nm 
N.P. 8 
nm 
4.5 
nm 
2.7 
nm 
N.P. 
BIR2 D.S. D.S. D.S. D.S. D.S. D.S. D.S. D.S. D.S. D.S. D.S. D.S. 
RING I D.S. D.S. D.S. I D.S. D.S. D.S. I D.S. D.S. D.S. 
IAP84 I I D.S. D.S. I I D.S. D.S. I I D.S. D.S. 
   
To summarize the bands present in the gels from above, samples were labeled as either 
“I” which stands for intact and signifies a high molecular weight band corresponding to 
the length of the undigested control dsRNA, or “D.S.,” which stands for diffuse staining 
and represents the presence of low molecular weight, diffuse bands, which is indicative 
of degraded dsRNA.  No particle types could protect the largest dsRNA, BIR2 (282 bp).  
Only the largest pore size, 8 nm, could protect the medium sized dsRNA, RING (184 bp).  
The IAP84 dsRNA (84 bp) was protected by the 8 nm and 4.5 nm pSNPs.  The digestion 
time did not result in different protection results, although the one hour digest could 
degrade the positive control.   
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Figure 3.4.  IAP84 dsRNA Transfer on 11.8 nm Mesoporous Silica Microparticles.   
Fluorescence recovery of fluorescently labeled IAP84 dsRNA on 11.8 nm microparticles 
saturated with unlabeled IAP84 dsRNA after 10 minutes (left) and 40 minutes (right).  
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Figure 3.5.  Fluorescent Microscopy Images of Sf9 Cells After Apoptosis Inducing 
and Non-Apoptosis Inducing Treatments. 
   
Sf9 cells were exposed to seven treatments:  cells only (panel A), cells + 8 nm pSNPs 
(panel B), camptothecin (panel C), RING dsRNA only (panel D), RING/8 nm pSNPs 
(panel E), EYFP dsRNA only (panel F), and EYFP/8 nm pSNPs (panel G).  Pictures in 
the first column (A, D, and F) contained no pSNPs while pictures in the second column 
(B, E, and G) contained pSNPs.  Using the camptothecin treatment as a reference image 
for typical apoptosis phenotypes (nuclear fragmentation, nuclear condensation, cell 
membrane deformities), and cells only as a healthy phenotype references, it was found 
that nanoparticles do not cause apoptosis but are retained by cells.  Exogenous dsRNAs, 
alone and in combination with nanoparticles, do not cause apoptosis.  When a segment of 
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the Inhibitor of Apoptosis gene, RING, dsRNA is delivered to Sf9 cells by nanoparticles, 
nuclear condensation and fragmentation is observed, which is indicative of apoptosis.  
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Chapter Four:  Epilogue and Conclusions  
The first step in assessing the viability of nanoparticles as a dsRNA delivery 
vehicle is to understand the relationship between dsRNA and porous silica nanoparticles 
(pSNPs).  This relationship can be characterized with confocal microscopy and 
fluorescence recovery after photobleaching (FRAP).  Because nanoparticles are too small 
to be observed with confocal microscopy, nonporous silica microparticles (SMPs) and 
porous silica microparticles (pSMPs) with equivalent chemistries and pore sizes were 
used as a model for pSNP-dsRNA interactions.  The initial goal was to characterize the 
conditions under which dsRNA loading into pSMPs occurred, namely how dsRNA length 
and particle pore size influenced dsRNA loading.  Because SMPs have no pores, only 
surface binding was observed in these samples.  Shorter dsRNAs of 84 base pairs (bp) 
loaded ubiquitously into all pore sizes, which indicates that this length of dsRNA is small 
enough to enter pores as small as 3.6 nm.  In contrast, the larger dsRNA (282 bp) 
exhibited only surface binding when associated with 3.6 nm pSMPs, which suggests that 
this dsRNA is too large to enter smaller pores.  282 bp dsRNA loaded ubiquitously into 
the larger 7.4 and 11.8 nm pSMPs, indicating that loading is not simply a function of 
correctly orienting the dsRNA molecule to the pore, perhaps indicating that loading may 
be constrained by both dsRNA and pore sizes.   
Upon discovering that dsRNA loaded into pSMPs in a pore size-dependent 
manner and that dsRNA molecules were mobile in pSMPs, further study was conducted 
to determine how dsRNA length, pSMP pore size, and dsRNA concentration influenced 
the mobility of dsRNA molecules when associated with pSMPs.  Fluorescent dsRNA 
molecules were associated with four types of microparticles:  nonporous, 3.6 nm porous, 
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7.4 nm porous, and 11.8 nm porous.  A laser was used to bleach a disk of fluorescent 
dsRNA, and then images were captured to track the recovery of fluorescence into the 
bleached area.  This procedure, referred to as fluorescence recovery after photobleaching 
(FRAP), is a tool used to characterize diffusivity, also known as mobility, of dsRNA 
molecules.  Two optical sections can be observed with this procedure:  the surface of the 
particle (the “cap” measurement) and the interior of the particle (the “core” 
measurement), which helps in determining if different locations in the particle influence 
dsRNA mobility.  dsRNA mobility was observed on pSMPs in a pore size and dsRNA 
length-dependent manner.  No mobility was recorded on nonporous SMPs for either 
length of dsRNA.  The shorter, 84 bp dsRNA was consistently more mobile than the 
larger 282 bp dsRNA.  Diffusivity of the 84 bp dsRNA was recorded for all pSMP 
samples, and was not statistically different at the cap or core of the particle.  282 bp 
dsRNA exhibited no mobility in association with 3.6 nm pSMPs, with mobility only 
observed in the 7.4 nm and 11.8 nm pSMPs samples.  The mobility of the 282 bp dsRNA 
was not statistically different on the cap or in the core of the particle when associated 
with 7.4 or 11.8 nm samples.  
Because diffusivity was only observed in pSMPs and not nonporous SMPs, this 
suggests that there is relationship between the dsRNA loaded into the pores and the 
movement of dsRNA.  To address this hypothesis, three concentrations of 84 bp dsRNA 
were associated with 11.8 nm pSMPs, loading was characterized, and then the FRAP 
experiment was conducted.  At the lowest concentration, 0.07 mg dsRNA/mg pSMPs, 
only surface binding was observed and no mobility was recorded.  At double that 
concentration, 0.13 mg/mg, ubiquitous loading was observed and dsRNAs began 
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exhibiting mobility.  At four times the original concentration, 0.25 mg/mg, uniform 
loading throughout the particle was observed and the dsRNA molecules were highly 
mobile.  The influence that dsRNA concentration has on loading and mobility indicated 
that there are several factors influencing the interactions between dsRNA and pSNPs, and 
that these factors should be studied in detail before exposing this system to in vitro and in 
vivo assays.   
After characterizing the relationship between dsRNA length, pore size, and 
dsRNA concentration on pSMP loading and dsRNA mobility, the next step in assessing 
the efficacy of pSNPs for delivery of dsRNA to insect cells was to analyze if pSNPs 
could protect dsRNA from nucleases.  One hypothesis for why RNAi does not work in 
lepidopterans is the presence of high numbers of DNA/RNA nucleases in lepidopteran 
midgut and hemolymph (and presumably in other insects that show little or no RNAi 
response) that degrade delivered dsRNA before it arrives at target cells (Bellés, 2010;  
Gatehouse and Price, 2011;  Gu and Knipple, 2013;  Terenius et al. 2011).  Nuclease 
activity has been observed in the hemolymph and digestive juices of two species of 
model lepidopterans, the tobacco hornworm Manduca sexta and the China silkworm 
Bombyx mori (Garbutt et al. 2013 and Liu et al. 2012).  Protecting the dsRNA from 
nuclease activity may solve one of the problems that may complicate the use of RNAi as 
a viable insect control strategy for RNAi-insensitive insects, and porous silica 
nanoparticles may be able to provide that protection.  
To assess how different types of silica nanoparticles protect dsRNA from RNase 
III, which is a double-stranded ribonuclease, four types of nanoparticles (nonporous, 2.7 
nm, 4.5 nm, and 8.0 nm porous) and three lengths of fluorescein-12-UTP dsRNA (84 bp, 
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184 bp, and 282 bp) were exposed to degradation by RNase III under increasingly 
stringent conditions.  Protection occurred in a pore size and dsRNA length-dependent 
manner.  The largest dsRNA, 282 bp, was not protected by any type of nanoparticle, 
which indicates that this dsRNA is too large to enter the pores and thus be protected from 
degradation.  The intermediate dsRNA, 184 bp, exhibited some protection from RNase 
III when it was associated with 8.0 nm pSNPs, but not when it was associated with other 
types of nanoparticles.  The smallest dsRNA, 84 bp, was well protected by both the 8.0 
and 4.5 nm pSNPs.  These data indicate that the larger dsRNA molecules traditionally 
used to induce an RNAi response may be too large to be protected by pSNPs, and that a 
smaller dsRNA associated with a large pore size may be more suitable for overcoming 
this obstacle.  
Another key factor in whether pSNPs can be used to effectively deliver dsRNA to 
insect cells is determining if dsRNA binding to pSNPs is reversible.  This is important 
because dsRNA molecules will need to become unbound from the pSNP once inside the 
insect cell.  If this binding reversal doesn’t occur, then the system is not appropriate for 
this application.  To address this question, non-fluorescently labeled 84 bp dsRNA was 
associated with 11.8 nm pSMPs (pSMPs were used in place of pSNPs for visualization 
with confocal microscopy) at a concentration of 0.25 mg/mg.  Then, an equivalent 
amount of fluorescein-12-UTP dsRNA was added to solution and the presence of 
fluorescence on the pSMPs was tracked with confocal microscopy.  Because the initial 
dsRNA used was unlabeled, only a black image was registered by the microscope.  As 
fluorescent dsRNA binds to the particles, the fluorescent signal increases as the number 
of fluorescently labeled dsRNA molecules bound to the surface of the particles increases.  
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This increase in fluorescence was observed after only 10 minutes, and continued to 
increase after 40 minutes.  These data indicate that dsRNA binding to particles is 
reversible and occurs quickly. 
The final test performed was to combine all of the collected information and 
expose Spodoptera frugiperda cells to dsRNA/pSNP complexes.  Because the 
intermediate length of dsRNA, 184 bp, had equivalent protection from RNase III in the 
8.0 nm pSNPs as the shorter 84 bp dsRNA and is closer to the length typically used to 
initiate an RNAi response, the intermediate dsRNA and 8.0 nm pSNPs were used in the 
cell viability assay.  Sf9 cells were exposed to seven treatments:  cells only (negative 
control for dsRNA only samples), cells + pSNPs (negative control for dsRNA + pSNP 
samples), camptothecin (positive control for all treatments), RING IAP dsRNA 
(apoptosis treatment), RING dsRNA + pSNPs, EYFP dsRNA (exogenous control), and 
EYFP dsRNA + pSNPs.  Apoptotic phenotypes were recorded by staining the nuclei with 
a Hoescht nuclear dye, and then the nuclei were observed with fluorescence microscopy.  
Cells in apoptosis exhibit nuclear condensation, nuclear fragmentation, and changes in 
cell membrane morphology that are easy to observe under a microscope, which makes 
this assay valuable for quickly observing changes occurring in samples.  Using this 
system, it was determined that pSNPs only and dsRNA only do not cause apoptosis under 
the tested experimental conditions.  Apoptosis was only observed when the RING 
dsRNA was delivered on pSNPs, with apoptotic phenotypes beginning to appear after six 
hours, which strongly indicates that the pSNPs facilitate the delivery of IAP dsRNA to 
cells and induction of apoptosis in these cells.  As time increased, the level of apoptosis 
increased until it was approximately 60% in the RING dsRNA + pSNP sample after 24 
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hours.  Some apoptosis was observed in the EYFP + pSNP sample, which may indicate 
that cells become apoptotic in the presence of any dsRNA associated with pSNPs, but 
there was a significant delay relative to cells receiving the IAP dsRNAs.  Although that 
conclusion is interesting, the marked difference in levels of apoptosis between the EYFP 
dsRNA + pSNP sample and the RING dsRNA + pSNP sample indicate that the 
phenotype is strongly gene dependent.  These preliminary data, in combination with the 
mobility and protection data, indicate that porous silica nanoparticles may be a viable 
strategy for inducing RNAi in RNAi insensitive insect species.  
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Appendix A:  Synthesis of Microparticles, Written by Shanshan Zhou 
Synthesis of Santa Barbara Amorphous Batch Mesoporous Silica Particles 
Spherical Santa Barbara Amorphous Batch (SBAS) materials were prepared using 
Schlipf’s synthesis procedure1.  Initially, 0.465 g of Cetyltrimethylammonium bromide 
(CTAB) dissolved in 20 mL of deionized water was added to 3.10 g poly (ethylene 
glycol)-block-poly (propylene glycol)-block-poly (ethylene glycol) (P123).  This solution 
was placed in a water bath at 30°C and stirred vigorously while 7.8 mL of 200 proof 
ethanol and 45.9 mL of 1.5 M HCl were added.  After the P123 was completely 
dissolved, 10 mL of tetraethoxysilane (TEOS) was slowly added drop wise.  This 
solution was mixed for 2 h.  At the end of 2 h, the solution was poured into a Parr 4748 
Teflon lined bomb, which had been acclimated to the hydrothermal aging temperature, 
between 60°C and 120°C, prior to use.  The sample was kept at the desired hydrothermal 
aging temperature in an oven for 3 days.  At the end of the 3-day period, the sample was 
removed from the bomb and mixed in a high-speed mixer to homogenize the solution.  
After homogenization, the sample was filtered and rinsed with deionized water.  After 
filtration, the sample was placed into a single walled Whatman cellulose extraction 
thimble, and the surfactants were removed using Soxhlet extraction with 200 mL of 200 
proof ethanol over 24 h.  The pore dimension (5-12 nm) increased as the hydrothermal 
aging (60-120°C) temperature increased.  
Nitrogen Adsorption 
Average pore diameter, pore size distribution and surface area were estimated 
from nitrogen sorption conducted at 77 K using Micromeritics TriStar 300.  Samples 
were degassed at 120ºC for a minimum of 4 h under flowing dry N2 gas before the 
nitrogen sorption experiment.  The specific surface area was estimated using the 
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Brunauer, Emmett and Teller (BET) isotherm, and average pore diameter and pore size 
distribution were estimated by the method of Barrett, Joyner and Halenda (BJH) for 
adsorption branch.  
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Table A.1.  Characterization Results for Non-Amine Functionalized and Amine 
Functionalized Microparticles.  
Particle type 
BET 
surface 
area 
(m2/g) 
Total 
pore 
volume 
(cm3/g) 
Average 
pore 
diameter 
(nm)b 
External 
surface 
area 
(m2/g)c 
Micropore 
volume 
(cm3/g)c 
Mesopore 
volume 
(cm3/g)c 
Nonporous 0.54a - - - - - 
Nonporous-A 0.54 - - - - - 
SBAS-3.6 
551 
0.81 
3.6 ± 1.4 702 0.028 
0.68 
SBASA-3.6 
191 
0.52 
3.0 ± 0.9 270 0.023 
0.42 
SBAS-7.4 
668 
1.27 
7.4 ± 1.1 849 0.033 
1.14 
SBASA-7.4 
400 
0.93 
7.2 ± 1.2 548 0.030 
0.86 
SBAS-11.8 
367 
1.82 
11.8 ± 2.6 451 0.011 
1.73 
SBASA-11.8 
319 
1.60 
11.3 ± 3.0 441 0.034 
1.56 
aSurface area determined by considering all particles as 5 µm diameter spheres;bThe average and range 
were determined from the peak and full width at half maximum (FWHM) of the BJH pore distribution, 
respectively, cFrom αs plot analysis 
BET surface area (m2/g), total pore volume as a function of pore diameter (cm3/g), 
average pore diameter (nm), and external surface area (m2/g), and micro- and mesopore 
volume (cm3/g) on bare silica microparticles (SBAS) and silica microparticles following 
amine functionalization (SBASA). 
References Cited 
1. Schlipf, D.M., Rankin, S.E., and Knutson, B.L. 2013. “Pore-size dependent protein 
adsorption and protection from proteolytic hydrolysis in tailored mesoporous 
silica particles.” ACS Appl Mater Interfaces. 5(20):10111-10117. 
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Appendix B:  Synthesis of Nanoparticles, Written by M. Arif Khan 
Materials & Methods 
Nonporous Stöber Particles (SNP) Synthesis 
SNPs were synthesized according to the method reported by Bogush et al. 
(1988).1  10 mL of deionized ultra-filtered (DIUF) water (3 M in ethanol) and 6.75 mL of 
28.5% NH4OH (0.5 M in ethanol) were added to 183.25 mL of ethanol.  The solution was 
stirred for 5 min.  Then, 7.6 mL of tertraethyl orthosilicate (TEOS) (0.17 M in ethanol) 
was added rapidly and the solution was stirred for 24 hours at room temperature.  The 
particles were separated from the solution using high speed centrifugation (17,000 rpm) 
followed by washing with DIUF water and ethanol 3 times.  Finally, separated particles 
were dried in an oven at 84ºC overnight. 
Mesoporous Silica Nanoparticle with Small Average Pore Diameter (pSNP-s) 
Synthesis 
Ordered mesoporous silica nanoparticles were synthesized by a modified Stöber 
method based on the report of Kim et al. (2010),2 where cetyltetramethylammonium 
bromide (CTAB) was used as a structure directing compound and TEOS and the tri-block 
copolymer Pluronic F127 were used as the silica source and dispersing agent, 
respectively.  Initially 0.5 g of CTAB and 2.05 g of F127 were dissolved in 96 mL of 
DIUF water, followed by the addition of 43.1 mL of ethanol and 11.9 mL of NH4OH 
solution (29.3 wt%) and the solution was stirred until complete dissolution of solutes.  
Then, 1.9 mL of TEOS was added to the solution and stirred vigorously for exactly 1 min 
at room temperature.  After that, the solution was aged for 24 h without any stirring at 
room temperature for complete silica condensation.  The particles were removed from the 
solution by ultrahigh speed centrifugation (Beckman-Coulter) at 17,000 rpm and were 
washed 3 times with DIUF water and ethanol with repeated centrifugation and dried at 
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80ºC in air overnight.  Finally, template free silica particles were obtained by washing in 
200 mL acidic ethanol (HCl 1.5 M) for 24 hours (acidic ethanol wash) followed by 
repeated centrifugation and washing with DIUF water and ethanol.  Template free 
particles were dried overnight at 84ºC. 
Mesoporous Silica Nanoparticle with Medium Average Pore Diameter 
(pSNP-m) Synthesis 
Synthesis of medium pore pSNPs was achieved by following the method reported 
by Gu et al. (2013).3  First, 0.4 mL of N,N-dimethylhexadecylamine (DMHA) and 0.1 g 
of Pluronic F127 were mixed with 1.02 g of octadecyltrimethylammonium bromide 
(OTAB) and 364 mL of water was added.  3.5 mL of 2 M NaOH solution was then added 
under stirring.  The solution temperature was raised to 80ºC, and kept stirring under 
constant temperature until a clear homogeneous solution was obtained.  Then, 5.0 mL of 
TEOS was added dropwise.  The solution was stirred at 80ºC for 2 h and cooled to room 
temperature afterwards.  The particles were separated by centrifugation and repeated 
washing with water and ethanol.  Template-free particles were achieved by the acidic 
ethanol wash described previously. 
Mesoporous Silica Nanoparticle with Large Average Pore Diameter (pSNP-l) 
Synthesis 
Large pore pSNPs were synthesized using a modified method described by 
Yamada et al. (2015)4 where 1,3,5-triisopropylbenzene (TIPB) was used as a CTAB pore 
expanding agent.  Initially, 0.56 mL of triethanol-amine (TEA) and 3.0 g of CTAB were 
added to 360 mL of DIUF water.  The solution was kept stirring at 80ºC for 2 h for 
complete mixing and emulsion formation and 15.96 mL of TIPB was added under 
vigorous mixing.  After 30 min, complete colloidal state (oil-in-water) was obtained and 
4.77 mL of tetrapropyl orthosilicate (TPOS) was added with constant stirring.  Then, the 
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solution was stirred vigorously for 12 h to obtain white solid particles.  The particles were 
then separated by repeated centrifugation and washing and the surfactant was removed by 
acidic ethanol washing.  
Amine Functionalization and Fluorescent Group Attachment 
Amine Functionalization 
Amine functionalized SNPs and pSNPs were obtained by condensing (3-
Aminopropyl)triethoxysilane (APTES) on the particle surface using a modified version of 
the methods reported in the literature.5, 6  200 mg of the particles (either SNPs or pSNPs) 
were sonicated in 25 mL of dry ethanol for 15 min and a uniformly dispersed solution 
was obtained.  0.5 mL of APTES was added drop wise under constant stirring and the 
solution was kept stirring overnight in a closed environment at room temperature.  
Particles were centrifuged at 17,000 rpm followed by repeated washing with dry ethanol 
and cured at 84ºC overnight.  After curing, particles were stirred in excess ethanol for 24 
hours to remove any remaining, loosely bound amine groups.  The functionalized 
particles were again washed 3 times with dry ethanol and dried in an oven at 84ºC.  
Amine functionalized nonporous and porous particles were denoted as SNPA and 
pSNPA, respectively. 
Fluorescent (RITC) Tagging 
Amine functionalized particles were suspended in 25 mL of dry ethanol after 
sonication for 15 min and 3.2 mg of rhodamine B isothiocyanate (RITC) was added to the 
uniformly dispersed solution.  After 24 hours of stirring, the bright red labelled particles 
were washed and centrifuged in ethanol repeatedly until the supernatant became 
completely clear and then dried in an oven.  The dry particles were then washed in water 
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and ethanol for 24 hours each to remove excess dyes and again dried in the oven 
overnight. 
Materials Characterization 
 The morphology and shape of bare and functionalized particles were 
characterized using a Hitachi S-4300 Scanning Electron Microscope (SEM) (Hitachi 
High-Technologies Corporation, Japan).  The samples for SEM characterization were 
prepared by dispersing the particles onto a double-sided carbon tap attached on a 15-mm 
aluminum mount.  Samples were put in a desiccator for 24 hours after excess silica 
materials were blown off with dry nitrogen gas.  Prior to analysis, the samples were 
coated with gold-palladium alloy using an Emscope SC400 (Quorum Technologies, 
Lewes, United Kingdom) with a gold-palladium alloy sputtering.  Average and standard 
deviation of particle diameters were calculated by considering 20 random particles 
throughout the SEM image using ImageJ Software (National Institutes of Health, 
Bethesda, MD).  Transmission electron microscopy (TEM), high resolution (HR) TEM 
and scanning-transmission electron microscopy (STEM) imaging were performed using a 
JEOL 2010F TEM (Jeol USA Inc., Peabody, MA) at a voltage of 200 kV.  Samples were 
prepared 3 days in advance by sonicating approximately 5 mg of particles in 2 mL of 
ethanol for 15 min.  Then a Lacey carbon 300 mesh copper grid (Ted Pella Inc., 01895-F) 
was dipped into the particle solution for 2-3 seconds and left in a desiccator before 
analysis.  Average pore diameter, pore size distribution and surface area were estimated 
from nitrogen sorption conducted at 77 K using Micromeritics TriStar 3000 
(Micromeritics Instrument Corporation, Norcross, GA).  Samples were degassed at 135ºC 
for a minimum of 4 h under flowing dry N2 gas before the nitrogen sorption experiment 
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was conducted.  The specific surface area was estimated using the Brunauer, Emmett and 
Teller (BET) isotherm, and average pore diameter and pore size distribution were 
estimated by the method of Barrett, Joyner and Halenda (BJH) for adsorption branch.  
Micropore volume and external surface area were estimated using the method described 
in Jaroniec et al.7  To confirm the successful removal of surfactant from SNP pores, 
Fourier transform infra-red (FTIR) spectroscopy was conducted using Thermo Nicolet 
Nexus 470 with a Deuterated triglycine sulfate (DTGS) detector before and after acidic 
ethanol wash (Thermo Fisher Scientific, Waltham, MA).  For the analysis, 0.5 g of 
anhydrous KBr was mixed was the particles (0.5-1.0 wt %) and the mixture was crushed 
using a mortar and pestle.  A small amount of the sample was put into the FTIR pellet 
dye to press until samples became translucent, rigid, and solid.  The pellet was then put in 
the FTIR pellet holder in the sample chamber under a constant flow of dry nitrogen and 
infra-red radiation was allowed to pass through it.  The FTIR spectra were recorded using 
Thermo OMNIC software (Thermo Fisher Scientific, Waltham, MA).  Low angle x-ray 
diffraction (XRD) analysis was performed using a Bruker-AXS D8 Discover 
diffractometer (Bruker, Billerica, MA) using an x-ray wavelength of 1.54 Å to determine 
the degree of mesostructural ordering.  Nanoparticles were scanned at 0.5°/min in 2θ 
increments of 0.02º from 1.5 to 6º.  Samples were prepared in a powder sample holder 
and tapped flat with a spatula.  Data analysis was performed with the Bruker Diffrac-
Suite software (Bruker, Billerica, MA). 
 Amine Quantification 
 The amount of amine group on the particle surface was determined by a modified 
version of the previously reported method,8 where primary amine groups in aminosilane 
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following dissolution in alkaline solution, reacts with fluorescamine to produce 
fluorescent pyrrolinone.9  30 mg of functionalized particles were dissolved over an 8 h 
period in 30 mL of 0.02 M NaOH solution at room temperature under vigorous stirring.  
100 μL of this solution and 1.0 mL of 1.0 mM fluorescamine in acetone solution were 
mixed with 2.0 mL of PBS solution at pH 7.4.  Maximum fluorescent intensity of this 
solution was measured at an emission wavelength of 480 nm after excitation at 366 nm 
using a Varian Cary Eclipse fluorescent spectrophotometer (Agilent Technologies, Santa 
Clara, CA), with both excitation and emission slits held at 5 nm.  Calibration curve was 
prepared using the same procedure by dissolving known amounts of APTES and 30 mg 
of non-functionalized pSNPs. 
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Characterization Results 
  
Figure B.1.  SEM Images of (a) SNP, (b) pSNP-s, (c) pSNP-m and (d) pSNP-l.   
SEM images for all four particle types that contain scale bars of 500 nm.  
 
  
(b) (a) 
(c) (d) 
84 
 
TEM of SNPs TEM of pSNP-s 
  
TEM of pSNP-m 
 
 
Figure B.2.  TEM Images of Nonporous and Porous Silica Nanoparticles.   
TEM images for 3 particle types:  SNPs with a scale bar of 0.1 µm, pSNP-s with a scale 
bar of 20 nm, and pSNP-m with a scale bar of 20 nm.  TEM images were not taken for 
pSNP-l. 
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Table B.1.  Surface Properties Characterization Results from Nitrogen Adsorption 
Experiments Before and After Amine Functionalization.   
Particle 
type 
BET 
surface 
area 
(m2/g) 
Total 
pore 
volume 
(cm3/g) 
Average 
pore 
diameter 
(nm)b 
External 
surface 
area 
(m2/g)c 
Micropore 
volume 
(cm3/g)c 
Mesopore 
volume 
(cm3/g)c 
SNP  14.4a - - - - - 
SNPA  14.4 - - - - - 
pSNP-s 953 1.21 2.20±0.16 135.6 0 0.818 
pSNPA-s 585 0.57 1.58±0.14 78.9 0 0.278 
pSNP-m 862 1.37 4.10±0.35 223.5 0.006 0.923 
pSNPA-m 366 0.66 3.24±0.38 159.9 0 0.255 
pSNP-l 729 2.32 7.90±2.15 618.6 0.017 0.823 
pSNPA-l 469 1.50 7.55±1.92 369.3 0 0.510 
aSurface area determined by considering all particles as 190 nm diameter spheres, bThe average and range 
were determined from the peak and full width at half maximum (FWHM) of the BJH pore distribution, 
respectively, cFrom αs plot analysis 
Measurements taken for surface property characterization include BET surface area (in 
m2/g), total BJH pore volume (in cm3/g), average pore diameter (in nm), external particle 
surface area (in m2/g), and the volume for micro- and mesopores (cm3/g). 
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Table B.2.  Monolayer Coverage of Amine Groups on Silica Surfaces8.   
 
 Nonporous 
2.7 nm 
porous 
4.5 nm 
porous 
8.0 nm 
porous 
Surface area (m2/g) 14.4a 953 862 725 
µl APTES/g SiO2 30.11 840.3 491.4 356.9 
mg APTES/g SiO2  28.6 798.3 466.8 339.1 
mmol APTES/g SiO2  0.129 3.61 2.11 1.53 
mg APTES/g particles  27.8 443.9 318.3 253.2 
mmol APTES/g 
particles  
0.125 2.00 1.44 1.14 
mmol APTES/m2 
surface 
0.00897 0.00378 0.00245 0.00211 
% of monolayer 
coverage 
272 114 74 64 
Surface area after 
functionalization (m2/g) 
- 585 366 469 
Pore volume before 
functionalization 
(cm3/g) 
- 1.21 1.37 2.32 
Pore volume after 
functionalization 
(cm3/g) 
- 0.57 0.66 1.50 
aSurface area determined by considering all particles as 190 nm diameter spheres 
Measurements taken for BET specific surface area, amount of amine grafted and % of 
monolayer surface coverage by amine group for amine functionalized nonporous and 
porous nanoparticles. 
50 Å2/amino-silane 
= 2.0 -NH2 containing molecule/nm2 
= 0.0033 mmol APTES/m2 surface 
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